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Abstract
 
The regulation of biological processes relies on a complex nucleotide code embedded in our 
DNA. Its decoding and interpretation is the main task of Transcription Factors (TFs), 
which altogether enable the recognition and modulation of gene expression. Whenever 
factors bind to DNA, a set of additional criteria and conditions need to be satisfied, such as 
TF concentration, DNA openness, and cooperativity with other binding factors. Such 
combinations of DNA-bound TFs, as well as their structural and functional cooperativity, 
allow a fine-grained control of gene expression due to subtle changes in specificity in both 
DNA recognition and functional outcomes. 
This thesis explores the prediction of structural TF cooperativity and its biological 
consequences. Through integration of publicly available TF binding data, we explore the 
prediction of determinants of TF-cooperativity across TF families, and validate our 
observations. By incorporating multi-omics data we set up a framework for annotation 
and scoring of ontologies associated to TF-TF binding, validating our findings using 
cancer expression data. Additionally, this thesis explores functional cooperativity between 
TFs in the context of neuronal activity, delineating rules that determine gene expression 
programs through up-regulation of specific TFs and their combinations. Finally, we 
investigate the TF-interactions in cell reprogramming, predicting and validating novel 
interactions between TF activators and repressors. Altogether, this dissertation provides 
an extensive set of insights to better understand the complex interplay between TFs 
cooperativity and phenotypes. 
 
Zusammenfassung 
 
Die Regulation biologischer Prozesse beruht auf einem komplexen Code aus Nukleotiden, 
der in unserer DNA eingebettet ist. Das Entschlüsseln sowie die Interpretation dieses 
Codes stellt die Hauptaufgabe der Transkriptionsfaktoren (Transcription Factors, TFs) 
dar, die insgesamt die Erkennung und Modulation der Genexpression ermöglichen. Wenn 
diese Faktoren an DNA binden, müssen allerdings eine Reihe zusätzlicher Bedingungen 
erfüllt sein, wie z.B. TF-Konzentration, DNA-Offenheit und Kooperativität mit anderen 
bindenden Faktoren. Solche Kombinationen von DNA-bindenden TFs, sowie deren 
strukturelle oder funktionelle Eigenschaften, ermöglichen eine genauere Kontrolle der 
Genexpression, aufgrund geringfügige Veränderungen in der Spezifität sowohl bei der 
DNA-Erkennung als auch in der funktionellen Auswirkung.  
Die vorliegende Dissertation untersucht Ansätze zur Vorhersage von struktureller TF-
Kooperatitvität und ihrer biologischen Folgen. Durch die Integration von öffentlich 
verfügbaren Daten, die TF-Interaktionen umfassen, untersuchen wir die Vorhersage von 
spezifischen Eigenschaften, die die Kooperativität zwischen TF-Familien begründen, und 
validieren unsere Beobachtungen in nachfolgenden Experimenten. Durch die 
Einbeziehung von Multi-Omics-Daten erstellen wir ein Framework für die Annotation 
und Bewertung von Ontologien für TF-TF Interaktionen und bestätigen unsere 
Beobachtung anhand von Expressionsdaten von Krebs-Patienten. Darüber hinaus 
untersucht die Dissertation die funktionelle Kooperativität zwischen 
Transkriptionsfaktoren im Kontext von neuronaler Aktivität und gibt Einblicke wie die 
Regulation spezifischer Faktoren und deren Kombination die Genexpression beeinflussen 
und bestimmen. Die vorliegende Arbeit nimmt ebenso die Wechselwirkungen von 
Transkriptionsfaktoren im Zusammenhang mit der Zellprogrammierung in Augenschein, 
sowie auch die Vorhersage und Validierung von spezifischen TF-Aktivatoren und -
Repressoren. Insgesamt stellt die Dissertation damit eine umfassende Studie dar, die mit 
neuen Einblicken und Ansätzen das komplexe Zusammenspiel  von 
Transkriptionsfaktoren, DNA-Erkennung und Phänotypen beschreibt.   
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Chapter 1 
 
Introduction
 
The development and maintenance of all biological events that constitute an organism 
requires a precise and robust control of all mechanistic steps involved to ensure the correct 
information flow. These control mechanisms are also pivotal to provide a dynamic yet 
precise response to environmental stimuli relevant for survival and reproduction. 
Evolution has allowed selection of millions of independent controlling strategies in 
different biological contexts, enabling the diversity in life we see in our world today. 
Concurrently, biological information flows and systems are also prone to defects that are 
associated with developmental failures and disease. 
The functional layers involved in sensing and responding to stimuli are important for 
translation of environmental signals into specific molecular mechanisms. Every complex 
and dynamic behavior, such as the fight-or-flight stress response or social behavior in 
bees [Bloch et al 2011], has an underlying molecular basis. At the same time, thousands of 
biochemical reactions take place in cells, ensuring homeostasis, survival and reproduction. 
Due to the importance of these reactions, a proper coordination is pivotal for ensuring 
specificity of the molecular control. 
The landscape of all possible reactions in an organism has been described over decades in 
Biochemistry research. Millions of these chemical steps dynamically occur at the same 
time. At the most rudimentary level these reactions rely on binary interactions between 
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metabolites and bio-molecules such as proteins, nucleic acids and lipids. The sum of all 
these interactions and their combinations define the molecular switches that allow signal 
transmission in the cell. 
1.1. Protein-DNA interactions and Transcription Factors  
Interactions between proteins and nucleic acids are important in a plethora of major 
biochemical processes, and arguably represent the most sensible regulatory control 
mechanism for genome readout. Such interactions maintain the tightness in genome 
architecture, DNA replication in cell division and control of gene expression. It is therefore 
pivotal that these biochemical reactions to remain efficient, precise and robust across 
generations. To date, different types of proteins DNA-interacting proteins are known 
[Rohs et al 2010] and their crucial functional roles manifest in their strong conservation 
levels in Prokaryotes [van Hijum et al 2009; Santos-Zabaleta et al 2018] and Eukaryotes 
[Nitta et al 2015; de Mendoza et al 2013]. 
Transcription factors (TFs) represent one of the most studied types of DNA-interacting 
proteins. These sequence-specific regulatory proteins exert control on gene expression by 
recruiting transcriptional complexes and chromatin modifiers, which effectively enhance 
or suppress transcription of nearby genes. Globally, TFs are classified based on the 
structural conservation of their DNA-binding domains (DBDs), which represent early 
determinants of gene expression control, and simultaneously evolved with specific roles in 
the three main kingdoms of life. Several of these DBDs have specialized through gene 
duplication and divergence in Eukarya, allowing functional diversification. For example, 
one family of TFs, the Zinc-Fingers (C2H2 ZF), contains approximately 800 members in 
humans. Current surveys estimate the number of TFs in humans to be around 2000 in total 
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[Lambert et al 2017]. Molecular processes such as splicing would mean that these numbers 
might be much higher with up to 8000 according to current estimates [Inukai et al 2017]. 
To understand how these regulatory factors recognize DNA, the protein-DNA interactions 
themselves need to be thoroughly investigated. Structural determination of TF-DNA 
complexes have revealed over-represented chemical interactions between TFs and DNA 
[Angarica et al 2008], restricting the number of biological features defining the protein-
DNA recognition code. These interactions have been classified as ‘Base-readout’ or 
‘Shape-readout’ according to how they bind the DNA molecule [Rohs et al 2010] (Fig 1.1). 
The first readout-mode is described by base interactions mediated by hydrogen bonds or 
Van der Waals contacts, while the second one is related to proteins ‘reading’ the overall 
structure of the DNA, including its electron density, electrostatic potential e.g. in the minor 
groove, and DNA-backbone. 
 
 
 
 
 
 
 
 
 
4 
 
  
 
     
 
Figure 1.1. Classification of protein-DNA interactions that confer specificity 
 (top) Protein-DNA complex between Transcription Factor FOXO1 (green) and its DNA binding site (gray). 
Interactions with the major groove bases (blue) indicate Base readout. The interactions between Forkhead 
wings and the neighboring DNA minor grooves are indicative of Shape readout. Visualization generated with 
PDIviz [Ribeiro et al 2015] (bottom) Classification of interactions types that determine recognition of DNA by 
proteins. Base readout is based on contacts residues and bases through hydrogen bonds, water mediated or 
hydrophobic contacts. Shape readout is based on the local and global structure of DNA, and it determines 
additional specificity. Adapted from [Rohs et al 2010]. 
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1.2. Methods to explore TF binding specificities 
Multiple experimental methods have been generated to study TF binding specificity. 
Techniques are primarily classified based on their readouts by microarray or deep-
sequencing methods. Microarray-based methods are prominently represented in the 
Protein Binding Microarray (PBM) technique [Berger et al 2006], in which a TF of interest 
is interrogated against a microarray containing DNA-oligos of known sequences. The TF is 
coupled to a Glutathione S-transferase (GST)-tagged domain, which is ultimately 
detectable with a fluorophore-tagged antibody (Fig 1.2). Binding efficiency can thereby be 
assessed by relative fluorescence across the array. This approach has been pioneered by 
the group of Martha Bulyk and has been used to systematically generate data for hundreds 
of Metazoan TFs. 
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Figure 1.2. Description of Universal Protein Binding Microarray experiment 
 (a) A single-stranded DNA microarray purchased from a provider is double-stranded using a low 
concentration of fluorescently labeled dUTP. (c) A GST-tagged TF is tested for binding to the DNA 
sequences in the microarray, using as a detection system a (d) fluorophore-conjugated antibody 
against GST. Adapted from [Berger and Bulyk 2009]. 
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Among deep-sequencing based methods, the systematic evolution of ligands by 
exponential enrichment (SELEX) is a practical way to generate TF-binding specificity 
readouts for TFs based on selection and sequencing of captured TF-specific DNA reads 
[Jolma et al 2010] (Fig 1.3). DNA reads are separated on a DNA gel (SELEX-seq; Spec-seq) 
[Riley et al 2014; Stormo et al 2015], or capture by column purification using the tagged 
TF of interest. Once reads are obtained, the experiment cycle can be repeated several times 
by re-amplifying the DNA-oligos and re-capturing with the TF, increasing the fraction of 
DNA sequences with high-affinity TF binding sites. Approaches based on SELEX for 
studying TF binding have been improved in recent years, allowing the high-throughput 
interrogation of hundreds of TFs in the same experiment (HT-SELEX) [Jolma et al 2013]. 
Additional adaptations of this experiment have allowed the interrogation of TF 
combinations (CAP-SELEX) [Jolma et al 2015], effects of methylation (methyl-SELEX) 
[Yin et al 2013], and addition of nucleosomes (NCAP-SELEX) [Zhu et al 2018]. One 
limitation of these studies is that the overall coverage per DNA-sequence is lower when 
multiple TFs are multiplexed in the same deep-sequencing run. To overcome this, 
conventional SELEX-seq with a higher sequencing deep has been adopted to explore the 
DNA-binding for longer DNA footprints [Zhang et al 2018]. Adaptations of SELEX-seq 
techniques that include DNA-modifications can be used to explore TF sensitivity to 
epigenetic variation (EpiSELEX-seq) [Kribelbauer et al 2017]. 
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Figure 1.3. Description of HT-SELEX experiment 
From a prepared DNA library with randomized DNA sequences of theoretically equimolar concentrations 
(Binding site library), a purified DNA-binding domain for a TF of interest (TF) is added and used for DNA 
selection based on protein-DNA interactions (Bound). Comparisons between Bound and the initial Binding 
Sites Library allow the assessment of features that confer protein-DNA specificity for the studied TF. Adapted 
from [Kinney et al 2019]. 
 
1.3. Modeling and prediction of TF-DNA binding interactions 
Research efforts in the field have tried to conceptualize interactions between TFs and DNA 
using a set of computational approaches that summarize TF-DNA interfaces and electron 
density at such interfaces into simplified and interpretable models. One of the earliest 
models proposed are the Position Weight Matrices (PWMs). These multinomial models 
were early described by Gary Stormo [Stormo et al 1982], and adapted by Thomas 
Schneider into a simplified visualization posited as Sequence Logos [Schneider et al 1990] 
(Fig 1.4). Due to its simplicity and fast interpretability such representations are 
commonplace in the field. However, they have been shown to not fully capture the 
complexity of protein-DNA experimental data [Weirauch et al 2011], highlighting the need 
of identifying the rules guiding these interactions, and ultimately introducing better 
models for community interpretation. 
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Figure 1.4. Additive models to display protein-DNA recognition. 
(a) Protein-DNA complex formed by the cAMP receptor protein (CRP) binding to its cognate binding site (PDB 
ID: 1CPG). Relative positions indicate DNA base pairs used for following visualizations. (b) Consensus binding 
site of CRP based on crystal structure (c) IUPAC motif based on DNA variants that are bound by CRP. (d) 
Energy matrix. Each weight represents the change in ΔG (-ΔΔG) expected when mutating the highest affinity 
DNA sequence in one position. (d) Weight matrix summarizing the relative increase or decrease in the 
expected probabilities for a selected set of binding sites with respect to a background distribution (e.g. 
genome-wide GC content). (f) Logo visualization for (d). Letter heights indicate -ΔΔG values. (g) Logo 
visualization for (e). Letter heights indicate weights increase or decrease. (h) Probability logo indicates the 
nucleotide probabilities for each position in the set of positive sequences. (i) Information logo summarizing 
the reduction of entropy in each position in (h) and highlighting the positions with the largest information 
values.  Adapted from [Kinney et al 2019]. 
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Historically, several such models for protein-DNA specificities in vitro have been proposed 
and made available [Weirauch et al 2011]. These models allow the quantification of DNA 
enrichment upon addition of a protein in sequencing data (“relative affinities” in SELEX 
data), or fluorescent signal for a DNA-oligo containing potential binding sites of interest 
in Protein Binding Microarray data. Proposed models are the ones with the highest held-
out performances, and summarize the most important DNA-recognition features as a set 
of mononucleotide and dinucleotide contributions (Fig 1.5). Recently, it has been proposed 
that models encompassing a full biophysical description of protein-DNA interactions are 
an adequate alternative to more complex Deep Learning based classifiers [Rastogi et al 
2018]. One of the main arguments for this is that Deep Learning models fail to consider the 
full spectrum of low affinity binding and ultimately fail in the prediction of those. To date, 
extended comparisons between traditional, biophysical and Deep Learning models for the 
prediction of DNA-binding sites in vivo would be required. However, the adoption and 
development of biophysical methods to score TF binding sites are delayed with respect to 
the vast amount of available tools and web services to obtain TF motifs from sequence data 
with PWMs [Bailey et al 2009].  
Simpler models describing protein-DNA interactions, on the other hand, are based on the 
collective grouping of sequence patterns enriched in in vitro experiments and their 
experimental readout as groups of k-mers [Mariani et al 2017]. These k-mers can be 
directly used to directly interrogate biological sequences with a higher signal-to-noise 
ratio due to the direct inclusion of patterns that are not necessarily robustly represented in 
Position Weight Matrices. 
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Figure 1.5. Commonly used features to describe TF-DNA interactions 
From a target sequence considered to be a putative binding site for a TF, the weights for features that are 
additively used to score the binding site relevance are scored using mononucleotides (additive features), 
proximal dinucleotides (neighbor features), non-local dinucleotides (pairwise features), and trinucleotide 
combinations (higher-order features).  Additionally, DNA pentamers can be assessed by their underlying DNA 
geometry (DNA shape features). Adapted from [Kinney et al 2019]. 
 
 
Altogether, the modeling of TF-DNA features allows the understanding of readout 
mechanisms contributing to TF binding. However, TFs do not act alone in vivo, and 
multiple biological features can affect their binding to DNA. The chromatin environment, 
methylation, coding and non-coding variation and interactions with other TFs are 
examples of such confounders (Fig 1.6) [Inukai et al 2017].  
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Figure 1.6. Features beyond binding primary TF motifs can modulate TF binding recognition. 
 (a) Various TFs can be in different binding modes, requiring additional models to describe all possible 
configurations. (b) Interactions with other TFs can confer additional cooperativity through protein-protein 
or DNA-mediated allostery. (c) Interactions with non-DNA interacting cofactors can modulate latent 
specificity TF-binding properties not activated in their presence. (d) Some TFs are specifically sensitive to 
methylation, and can increase or decrease their binding potential upon DNA-methylation. (e) The local DNA 
shape can determine TF binding specificity. (f) The genomic context can determine that some TFs will be 
preferably recruited to certain sites according to the chromatin state or nucleosome placement. (g) Coding 
(star) and non-coding (shown as X on binding site) variation adds additional complexity in TF binding. 
Adapted from [Inukai et al 2017]. 
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1.4. TF interactions and cooperativity as an additional regulatory layer of 
biological function 
As TFs can also form complexes with other TFs the spectrum of possible interactions and 
regulatory switches increases dramatically [Morgunova et al 2017] (Fig 1.7). 
Biophysically, most of these TF-TF complexes with DNA require few or no protein-protein 
interactions at all [Jolma et al 2015]. 
Several efforts have been made to formulate the systematic prediction of composite TF-TF 
binding sites in vivo [Guturu et al 2013; Jankowski et al 2014]. Recent experimental 
surveys have described these interactions to be promiscuous and widespread across TF 
families, and estimate the amount of interactions to be around 25000. In fact, 1 out of 100 
possible TF-TF pairs in the human genome are expected to form a cooperative pair. The 
implications of this kind of TF-TF interactions remain elusive but undoubtedly define yet 
another regulatory layer with functional consequences, as there are multiple cases in 
which TF-TF binding has been shown to be associated to downstream biological function. 
Examples are the homeodomain dimers in development [Slattery et al 2011], or the 
olfactory receptor regulation through Lhx2-Ebf binding [Monahan et al 2017]. 
Genetically, it has also been shown that Genome-Wide Association Studies (GWAS) 
variants affect immune function through disruption of IRF4-BATF complex binding 
[Iwata et al 2017]. 
As these interactions seem to be prevalent in particular configurations [Jolma et al 2015], 
they are limited to specific TF-family cooperative binding events. Interestingly, these 
complexes have been shown to bind similarly across members of the same TF-families, 
and to recognize low-affinity binding sites collectively across the whole family, such as in 
the SOX-PAX family pair [Narasimhan et al 2015]. This highlights the need of models that 
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take those families into account as well to provide better cooperative binding predictions 
in vivo. 
                                     a 
 
 
                                             b 
    
Figure 1.7. Types of interactions between TFs when bound to DNA. 
(a) (top) Depiction of protein-level TF-TF complex with DNA. (bottom) From left to right in both rows: 
lambda-repressor (PDB: 3BDN); NF-Y trimer (alpha/beta/gamma subunits in green, cyan and magenta, 
respectively) (PDB: 1CF7); p53 tetramer (PDB: 2AC0); HNF1 homodimer (PDB: 1IC8); E2F8 domains (PDB: 
4YO2); two GATA zinc-finger domains (PDB: 3DFV); three Zinc-finger domains of GLI (PDB: 2GLI). (b) (top) 
Depiction of DNA-facilitated or DNA-mediated TF-TF complex. (bottom) left to right in both rows: TBX3 
bound to palindromic site (PDB: 1H6F); SOX2:Oct1 complex (light yellow and dark yellow, respectively) (PDB: 
1O4X); HOXA9:PBX1 (green and dark blue, respectively); AML1:RUNX1 (green and yellow) (PDB: 1HJB); 
NKX2.5:TBX5 (pink and green) (PDB: 5FLV); IRF3:ATF-2:c-JUN (green, violet and magenta) (PDB: 1T2K). 
Adapted from [Morgunova et al 2017]. 
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1.5. Profiling the accessible genome 
To study such TF-DNA interactions it is necessary to profile genome-wide chromatin 
accessibility. Recently, a new methodology to quantify genome-wide chromatin 
accessibility called Assay for Transposase-Accessible Chromatin using sequencing (ATAC-
seq) has been introduced as a powerful and lower cost alternative to previous approaches 
[Buenrostro et al 2013] (Fig 1.8). The technique relies on the usage of a mutant Tn5 
transposase that is hyperactive and inserts adapters in the open regions of the genome, by 
tagmentation. These fragments are prepared for sequencing by DNA purification and PCR 
amplification. Processing of reads via mapping and comparison between treatments allow 
the overall annotation of regions with gained, closed or unchanged chromatin 
accessibility. Specific analyses of the DNA sequences that are cover regions with changed 
accessibility allows mapping TF motifs and footprints that describe overall physical 
properties of potential TF binding in such loci [Schep et al 2017]. 
1.6. TF combinations orchestrating the chromatin environment and gene 
expression 
The combinatorial role of TFs when binding to the accessible genome is understood as a 
collective recruitment of several factors in order to activate or repress a signal [Spitz et al 
2012]. As such, the very minimum amount of TFs is required to be recruited in order to 
modify the chromatin environment, increase or decrease gene expression of local genes 
and ultimately initiate a regulatory response. 
However, not all TFs can bind to nucleosome-occluded DNA without the prior binding of 
other factors that would open the chromatin structure. TFs with this capacity are known as 
“pioneers”, based on their ability to displace nucleosome and open chromatin regions 
where they become bound [Mayran et al 2018]. As the binding of TFs without this property 
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at nucleosome-occluded DNA relies on such TFs, the binding of pioneer TFs is usually 
followed by co-regulators that bind motifs at those sites but do not actively open the 
surrounding chromatin. Given that not all TFs have an associated pioneering activity, the 
interactions between pioneer and non-pioneer factors is pivotal for our understanding of 
recruitment events in the first place [Mayran et al 2019]. 
TF binding is highly dependent on these chromatin accessibility changes, with accessible 
regions being enriched for pioneer and co-regulator TF motifs in a positional way [Su et al 
2017] (Fig 1.9). Relating chromatin accessibility changes to regulatory mechanisms 
through the recruitment and interactions of those factors is therefore undoubtedly a 
contemporary challenge. These relationships are the main topic of Chapter 3, where 
connections between neuronal activity and chromatin accessibility are studied. 
 
 
 
Figure 1.8. Schematic illustration of the ATAC-seq protocol. 
 (left) Visualization of chromatin regions with closed or open conformations (middle) addition of hyperactive 
Tn5 transposase tags  open regions (right) purification, PCR amplification and deep-sequencing of tagged 
fragments and mapping indicates regions of high accessibility. Adapted from [Buenrostro et al 2017]. 
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Figure 1.9. Working model of neuronal activity based on pioneering and co-regulators recruitment to 
regulatory DNA sequences. 
Upon neuronal stimulation (e.g. with KCl), specific TFs with pioneering activity such as the ones with bZIP 
domains (cFos), bind to nucleosome-occluded regions and displace nucleosomes, increasing the overall DNA 
accessibility in those regions. Next, co-regulator TFs without pioneering activity (green, blue, brown) can 
bind to DNA and mediate gene response by enhancer remodeling and enhancer-promoter interactions. 
Finally, the pioneer factor is decreased in expression and its binding is not required anymore, but co-
regulators are maintained in activated regions. Adapted from [Su et al 2017]. 
1.7. Cooperative binding of TFs involved in differentiation and reprogramming 
It has generally been understood that TF combinations play a relevant role in determining 
cell differentiation, and conversion of cell types. One of the most important discoveries in 
the field of regenerative medicine has undoubtedly been the reprogramming of fibroblasts 
into induced pluripotent stem cells (iPSCs), using a specific combination of TFs known to 
be over-expressed in this type of cells (Sox2/Klf4/Oct4/Myc, or the Yamanaka Factors) 
[Takahashi et al 2006]. 
Most reprogramming experiments have been done in fibroblasts, and it is still unclear 
whether it is possible to trans-differentiate every single cell type into any other target cell 
type [Fu et al 2017]. Apart from identifying the activating TFs, other mechanistic rules 
need to be dissected. The epigenetic memory involves tagging specific chromatin regions, 
which would need to be chemically removed to allow robust differentiation [Ng et al 
2008]. Dissecting such interactions between TFs and epigenetic modifications has proven 
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useful to further understand how a cellular fate is maintained after reprogramming 
[Holmberg et al 2012; Hörmanseder et al 2017]. 
At the same time TFs with roles in repression of non-cell fate genes have also been 
suggested to be important. The first of its kind, described in neurons, is the Myelin 
transcription factor 1 like (Myt1l) [Vierbuchen et al 2010]. This factor is able to increase 
the reprogramming efficiency of Mouse Embryonic Fibroblast into induced neurons 
[Vierbuchen et al 2010], and has been linked to the active repression of genes related to 
non-neuronal pathways [Mall et al 2017]. Given that Myt1l is overexpressed in most 
neuronal subtypes but it is absent in almost all other tissues, this factor is deemed a 
“terminal repressor” of non-neuronal cell fates relevant for neuronal fate maintenance. 
This concept allows speculation about the possible existence of such terminal repressors in 
other cell types opening an exciting avenue to be explored further. Indeed, such unknown 
factors with terminal repressor potential in other cell types can prove valuable for 
redesigning current reprogramming protocols for the purpose of increasing specificity and 
efficiency. This topic is certainly of relevance given that most tools used for predicting 
reprogramming do not include this feature to date [Rackman et al 2016]. Ultimately, 
annotating such terminal repressors would give better insight into how cells require them 
for robust differentiation. Moreover, many neuronal diseases are related to mutations in 
Myt1l [Blanchet et al 2017], and it can thus be expected that potential terminal repressors 
are also related to disease in many other cell types. 
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1.8. Aims of the Thesis. 
Given the current state and recent efforts in the TF recognition field, several questions 
remain unanswered. In the following Chapters, we seek to precisely answer the following 
questions (Fig 1.10).  
Question 1: Can we identify TF-cooperativity and features allowing its prediction in 
published TF-binding data? 
Based on the idea that TF cooperativity is able to leverage low-affinity binding sites and 
confer additional specificity to certain TF-motifs, this dissertation explores the inference 
of TF cooperativity from in vitro data. Specifically, the first section of Chapter 2 describes 
the integration of publicly available CAP-SELEX, as well as biophysical and biochemical 
experiments that are used to explore this question. The data is effectively summarized into 
a framework for the unbiased assessment of DNA sites that are preferably bound by TFs in 
a cooperative manner.  
Question 2: What are the consequences of cooperative TF-binding in function and 
disease?  
Given that multiple TF-TF complexes are expected to bind DNA cooperatively, there is the 
possibility of numerous novel associations between TF interactions and downstream 
function to be identified and investigated. Approaches to address this question are 
introduced and applied in the second part of Chapter 2. Our framework associates specific 
TF-cooperative binding k-mers present in ChIP-seq data with downstream functional 
consequences. Our argument on deriving ontology connections leveraging cooperative TF-
binding was substantiated by recovery of functional ontologies linked to the individual 
TFs, and the validation of interesting cases in development and disease. 
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Question 3: What is the interplay between TFs and chromatin accessibility and how does 
it confer specific neuronal activity? 
This question is addressed in Chapter 3, which presents an integrative study of multi-
omics data in mouse cortical neurons. Chromatin accessibility profiled by ATAC-seq is 
used to assess immediate response by TFs and their associations to gene expression 
programs. The data demonstrates that particular TFs and their interactions drive specific 
responses in each condition, precisely modulating neuron function. 
Question 4: Embargoed until 15 Sep 2021  
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Figure 1.10. Visual overview of the main chapters of the dissertation. 
Relationships between TF-TF cooperativity and function are studied in Chapter 2. Functional coordination 
between TFs binding and gene expression in the context of neuronal activity is presented in Chapter 3. 
Finally, in Chapter 4 the relationship between combinations of activator TFs (blue, red) with Terminal 
repressor TFs (yellow, green) is explored and discussed is the context of cell reprogramming 
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Chapter 2 
 
Mechanistic insights into transcription factor 
cooperativity and its impact on protein-phenotype 
interactions 
 
In this chapter, I describe the analyses and results of a project exploring prediction of TF 
cooperative binding and their consequences. The methodology behind this work has been 
conceived by me, and I carried out all computational analyses, with support from other authors. 
The data underlying this analysis was obtained from published articles, as specified throughout 
this chapter. Additionally, biophysical and biochemical validations were generated by Nele M. 
Hollmann, Sandra A. Augsten, and Janosch Hennig. The work has been described in the 
following manuscript:
Ignacio L. Ibarra, Nele Merret Hollmann, Bernd Klaus, Sandra Augsten, Britta Velten, 
Janosch Hennig & Judith B. Zaugg (2019). Mechanistic insights into transcription factor 
cooperativity and its impact on protein-phenotype interactions. Submitted.
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2.1. Introduction 
Transcription factors (TFs) are essential for regulating cellular functions. This regulation 
is based on very specific protein-DNA interactions. For comprehending the regulation of 
biological processes it is therefore crucial to understand how TFs recognize their specific 
DNA binding sites [Spitz et al 2012; Stormo et al 2013]. 
The major determinants conferring TF binding specificity are the DNA sequence and DNA 
shape readouts [Rohs et al. 2010]. The former is guided by interactions between amino 
acids and DNA bases, whereas the latter is driven by the DNA structure preference of 
proteins mediated through DNA-backbone and DNA minor groove contacts. While 
sequence readout is a major driver of specific TF-DNA interactions, DNA-shape features 
improve the binding predictions for certain TF families both in vitro [Zhou et al 2015; Yang 
et al 2017] and in vivo [Mathelier et al 2016]. 
To date, over 1600 human TFs are annotated in the human genome [Lambert et al. 2017]. 
For many of them their DNA-binding preferences, summarized as TF motifs, have been 
determined either through in vitro assays [Badis et al. 2009; Jolma et al. 2013; Jolma et al. 
2015; Weirauch et al. 2014; Mariani et al. 2017] or in vivo through chromatin 
immunoprecipitation followed by sequencing (ChIP-seq). However, despite the wealth of 
data and a good agreement between in vivo and in vitro derived TF motifs [Orenstein et al 
2014] one of the long-standing challenges in the field is the high number of TF binding 
events that cannot be explained by the primary motif of the assayed TF. One of the 
proposed explanations for this phenomenon is that TFs can bind cooperatively and thereby 
strengthen their DNA binding affinity [Morgunova et al. 2017]. 
Recent studies leveraged high-throughput Systematic Evolution of Ligands by Exponential 
Enrichment coupled to Consecutive Affinity Purification (CAP-SELEX) [Jolma et al. 2015] 
to identify composite sites where cooperative TF-binding may occur. However, despite 
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these experimental advances, for most TFs the molecular mechanisms of cooperative 
binding and its distinction from co-binding remain elusive. Furthermore, even though it 
has been demonstrated that specific TF-TF interactions can alter sequence recognition 
through the formation of homo- or heterodimers, and are important for driving specific 
biological processes [Slattery et al 2011; Monahan et al 2017; Huang et al 2015], we lack a 
global understanding of the consequences of cooperative TF binding. This is mainly 
because we are missing the appropriate computational tools to systematically interrogate 
their functional associations. 
Here, we implemented a framework to determine cooperative TF-binding preferences 
from in vitro SELEX data. We identified DNA shape as an important feature to predict 
cooperative TF binding, in particular for pairs between Forkhead and E26 transformation 
specific (Ets) members. This particular prediction was validated using nuclear magnetic 
resonance (NMR) spectroscopy and isothermal titration calorimetry (ITC). Through site-
specific amino-acid mutagenesis we further showed that DNA shape readout likely 
contributes to the cooperativity mechanism. In vivo enrichment of these cooperative 
sequences indicates different prevalence across Forkhead-Ets pairs, suggesting an 
additional layer of regulatory complexity. Finally, through an extensive assessment of the 
biological consequences of TF-cooperativity in vivo we found that leveraging the 
knowledge of cooperative TF binding increases the power to discover functions regulated 
by TF pairs. Specifically, for the Forkhead-Ets families we showed that a joint upregulation 
of FOXO1-ETV6 in Chronic Lymphocytic Leukemia (CLL) patients was associated with 
significantly higher survival rates. 
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2.2. Results 
2.2.1. Quantitative modeling reveals contribution of higher order sequence 
features to TF-cooperativity 
In a recent study Jolma et al have reported hundreds of cooperatively bound TF pairs 
through CAP-SELEX experiments [Jolma et al. 2015]. Their study demonstrated that TF 
cooperativity is highly prevalent and proposed that a majority of TF pairs do not directly 
interact, but form complexes mediated by DNA. Here we wanted to gain more insight into 
the mechanisms and uncover general rules that drive cooperativity among the identified 
TF pairs. Specifically, we hypothesized that features encoded in the DNA may contribute to 
the observed cooperativity. To test this, we devised a framework to predict the relative 
affinity of TF pairs based on DNA features using CAP-SELEX data. By ranking the 
importance of each DNA feature we could then identify those that potentially drive 
cooperativity. 
CAP-SELEX data was obtained from Jolma et al [Jolma et al. 2015]. After reprocessing and 
quality control (Appendix A) we built models to predict the relative affinity of k-mers 
(DNA sequences of length k) bound to TF pairs in a procedure adapted from Riley et al 
[Riley et al. 2014], which was previously employed to identify DNA features that determine 
binding of mainly single TFs [Zhou et al 2015, Mathelier et al. 2016; Yang et al. 2017; Rube 
et al. 2018]. Relative affinity was defined as the enrichment of a k-mer in the last cycle of 
the SELEX experiment relative to its input abundance. We then compared the performance 
of a basic model, which predicted the relative TF affinities from the mononucleotide 
sequence (1mer) with models that included more complex features, such as dinucleotides, 
trinucleotides (2mer and 3mer) or DNA-shape (shape) [Zhou et al 2015]. The latter models 
may capture DNA stacking interactions, local-structure elements, and the overall DNA 
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structure, respectively (Fig 2.1a) [Rohs et al 2009; Zhou et al 2015]. The models were 
implemented as L2-regularized multiple linear regression (L2-MLR), and the impact of 
the features on TF-binding was assessed by calculating the relative improvements 
measured as R² differences on testing data (ΔR²) between the full model (1mer+shape/ 
1mer+2mer/ 1mer+2mer+3mer; 12, 20 and 84 features per position, respectively) and the 
reduced model (1mer - 4 features per position) using cross validation (Appendix A). 
For each TF pair, we used the reported consensus sequences [Jolma et al 2015] as 
references for k-mer selection, considering all sequences up to a defined number of 
mismatches, along with their relative affinity values (Appendix A). One challenge that 
arises when working with composite TF binding models, is that their DNA binding regions 
are often very long and require high k values, which leads to low coverage of k-mers and 
hampers relative affinity estimates. Therefore, we developed a “trim-and-summarize” 
approach where we generated sets of tiled k-mers for each original k-mer of lengths no 
shorter than ten nucleotides, and summarized their effect on the prediction as a median R² 
(Fig 2.1a, Fig S2.1a-b; Appendix A). This resulted in 507 composite motifs with relative 
affinity estimates, comprising 77 unique TFs in 280 unique TF pairs. We found that models 
including higher-order features (1mer+2mer, 1mer+2mer+3mer, or 1mer+shape) performed 
consistently better than sequence-only models (1mer) (mean P < 1.0 x 10-6; Wilcoxon rank-
sum test). 
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Figure 2.1. Addition of DNA-shape features improves combinatorial binding predictions in CAP-SELEX data. 
 (a) (1) Description of “trim-and-summarize” approach to obtain relative affinities for composite motifs (k-
mers): a reference k-mer from CAP-SELEX data is trimmed from either side into multiple tiled k-mers with 
lengths no shorter than ten (blue regions assigned to consensus sequence for FOXO1 in reported k-mer, green 
regions assigned to ELK3 consensus sequence in reported k-mer) (2) L2-regularized multiple regression 
model (L2-MLR) are generated using DNA features as predictors and relative affinities as response variables 
(Appendix A). DNA sequence features (1mer, 2mer, 3mer) and DNA shape features (MGW, ProT, HelT, Roll), are 
tested in different combinations to assess their prediction contributions (3) A consensus improvement for 
each reference k-mer and model is obtained by cross-validation in each tiled k-mer table (10-fold CV) and 
calculation of the median tiled k-mer R2 improvement for all cases. (b) Trim-and-summarize testing R2 
values are shown for each CAP-SELEX and reference k-mer combination, using tiled k-mers. Values above the 
diagonal indicate improvements in the testing set prediction performance when using mononucleotide and 
shape features together (1mer+shape, y-axis), with respect to models with only mononucleotide features 
(1mer, x-axis). Relevant TF family and TF family pairs are labeled by colors (Others = non-labeled families). 
(c) Trim-and-summarize ΔR2 differences between 1mer+shape versus 1mer, stratified by family, (P indicates 
Wilcoxon test adjusted P-values, corrected by Benjamini Hochberg’s procedure). 
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This indicates that higher-order features are important for predicting TF cooperative 
binding (Fig 2.1b). Notably, since the predictions were done on held-out data, the positive 
ΔR² is not due to overfitting. 
Overall, regardless of whether high-order sequence features are interpreted as “DNA 
shape” or as “dinucleotide dependencies”, our results point towards their important role 
in guiding co-operative TF binding. In the following, we will only use 1mer+shape models, 
which reasonably capture the improvements observed for the other models (Fig S2.1c-d). 
2.2.2. Forkhead-Ets cooperativity is driven by DNA shape features 
We next sought to assess whether DNA shape was important in driving cooperativity 
between particular TF families. To do so, we compared the ΔR² between full (1mer+shape) 
and basic (1mer) models across all TF pairs stratified by family. In agreement with previous 
studies we observed a moderate but significant increase in ΔR² for TF pairs involving 
homeodomain members [Slattery et al 2011; Abe et al 2015; Yang et al 2017]. (Fig 2.1c, 
median ΔR² = 0.07; P = 1.4 x 10-3, one-sided Wilcoxon rank-sum test; (Appendix A). The 
strongest effect of DNA shape, however, was observed for pairs between Forkhead and Ets 
members (median ΔR² = 0.09, P = 1.8 x 10-5). This shape-dependency was more 
pronounced than the ones obtained for each family alone (Forkhead and Ets median, both 
ΔR2=0.07) thus highlighting its specificity. This is particularly interesting because 
crystallographic studies have demonstrated that DNA shape varies across Forkhead 
members [Li et al 2017]. In addition, Ets binding predictions have shown improvements by 
DNA-shape features [Yang et al 2017]. 
Due to the known bi-specificity of Forkhead TFs [Nagakawa et al 2011], we performed the 
same analysis after discarding DNA sequences containing the bi-specific Forkhead motif, 
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and obtained comparable results (Fig S2.1d). Overall, these observations highlight that 
DNA shape (or high-order features captured by shape) are important for predicting 
composite binding in a subset of TF-families, and particularly so for Forkhead and Ets 
members. 
2.2.3. Prediction and validation of cooperativity between Forkhead and Ets 
We next wanted to gain more mechanistic insight into the specific sequences presumably 
driving cooperativity between members of the Forkhead and Ets families and that could 
potentially explain TF binding to non-canonical sites. For that purpose, we used FOXO1 
and ETS1 as a prototype Forkhead-Ets pair, and classified DNA sequences based on their 
level of cooperativity. Specifically, for each k-mer we compared the relative affinities for 
ETS1 and FOXO1 obtained from their respective High-Throughput SELEX (HT-SELEX) 
datasets (Fig 2.2a), and defined their cooperativity-potential as the ratio of predicted 
relative affinities between FOXO1:ELK3 (ETS1 paralogue) and the mean predicted relative 
affinity for FOXO1 and ETS1 (Appendix A). We found that the cooperativity potential 
dropped with increasing FOXO1 binding affinity, while the relative affinity of ETS1 had 
little effect on it (Fig 2.2b). This indicated that the FOXO1-binding strength determined the 
level of cooperativity, conclusion further corroborated by comparing representative DNA-
sequences classified as non-cooperative, cooperative and highly cooperative (ω-none, ω 
and ω-high, respectively Fig 2.2c), which only differed in their Forkhead binding region. 
Similarly, Universal Protein-Binding Microarray data [Berger et al. 2006] revealed higher 
affinity of Forkhead members for ω-none than for ω sequences, while weak binding was 
observed for ω-high (Fig S2.4a; Appendix B). These results suggest that Forkhead TFs can 
bind to ω-none sequences on their own by recognizing a strong Forkhead binding site 
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while they rely on allosteric interactions with their Ets partner for recognizing ω (and 
possibly ω-high) sequences by forming a cooperatively bound ternary complex. 
To validate the cooperativity predictions experimentally, we used isothermal titration 
calorimetry (ITC) to monitor changes in the dissociation constants (Kd) for the three DNA 
sequences with FOXO1 alone and in the presence of ETS1 (Appendix B). For FOXO1 alone we 
observed a 10-fold stronger binding for ω-none than for ω (Kd= 24 ± 3 nM and 352 ± 22 
nM, respectively; P < 0.01, two-sided t-test Fig 2.2d; Fig S2.2a) while no interpretable 
results were obtained for ω-high of ITC. To test the effect of cooperativity on FOXO1 
binding we titrated FOXO1 into a mixture of each DNA sequence and ETS1 and indeed 
observed a significant reduction in the Kd for ω (44 ± 11 nM; P < 0.01), but not for ω-none 
(26 ± 2 nM). This indicates cooperative binding between FOXO1 and ETS1 for ω but not for 
ω-none and thus validates our predictions. Since we were not able to measure ω-high 
using ITC, we resorted to measuring NMR chemical shift perturbations (Fig 2.2e; S2.3a), 
interpreted as weak, moderate or strong binding depending on the exchange regime (fast, 
medium, slow) to assess cooperativity between FOXO1 and ETS1. The results for ω and ω-
none were corroborated qualitatively by NMR, as chemical shift perturbations switched 
from intermediate- to slow-exchange regimes, indicating an increase in binding affinity 
for ω in presence of ETS1 (Fig 2.2e). Additional peaks also show a similar behavior (Fig 
S2.3b-c). For ω-none, we observed slow-exchange (stronger binding) for both FOXO1 
alone and in the presence of ETS1. Importantly, for FOXO1 on ω-high we observed 
chemical shift perturbations in the fast exchange regime, which enabled fitting and 
affinity determination. FOXO1 bound to ω-high three orders of magnitude weaker than ω-
none (Kd = 21 ± 40 µM; Fig 2.2f) and changed to the intermediate exchange regime in 
presence of ETS1, indicating stronger binding and consistent with a cooperative 
interaction. 
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To generalize our cooperativity prediction to other FOXO1-Ets pairs binding in an 
equivalent conformation, we assessed the relative affinities of FOXO1 for sequences 
containing the binding patterns present in ω-none and ω (5’-GTAAACA-3’ vs 5’-
AACAACA-3’) in single (HT-SELEX) and paired (CAP-SELEX) data. As expected, FOXO1 
showed significantly higher relative affinities for ω-none versus ω in HT-SELEX late 
rounds (Fig S2.3b, Appendix A). In CAP-SELEX, however, relative affinities for ω-none 
and ω were similar for the majority of datasets comprising FOXO1 paired with Ets, 
Homeodomain and GCM members. 
In summary, our framework to predict cooperativity for FOXO1-ETS1 pairs based on 
combining single-TF HT-SELEX and paired-TF CAP-SELEX data was experimentally 
validated by ITC and NMR. Our findings suggest a widespread mechanism whereby 
Forkhead TFs recognize non-optimal binding sites through cooperative interaction with 
specific partner TFs. 
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Figure 2.2. Prediction and validation of cooperative binding sites from SELEX data 
(a) Workflow describing the calculation of the cooperativity potential between k-mers from CAP-SELEX and 
matched HT-SELEX data. Predicted relative affinity values of k-mers from CAP-SELEX data are scaled by the 
mean value observed in HT-SELEX for the matched single TF datasets. (b) Comparison relative affinity 
predictions for ETS1 and FOXO1 for 15-mers using HT-SELEX. K-mers are weighted by their estimated 
cooperativity potential using CAP-SELEX of FOXO1:ELK1 and HT-SELEX datasets for FOXO1 and ETS1 (ELK1 
paralogue). Y- and X-axes indicate predicted relative affinities for ETS1 and FOXO1 datasets, respectively, 
using 1mer+shape models. (c) (top) Cartoon description of binding mode for the FOXO1-ETS1 ternary 
complex. (bottom) Sequences chosen for validation from regions of none (ω-none), moderate (ω) and high 
(ω-high) cooperativity are shown and aligned with Forkhead-Ets composite motif. Green and yellow 
highlighted regions indicate Forkhead and Ets binding regions, respectively. (d) Dissociation constant ITC 
measurements for FOXO1 with ω-none and ω DNA sequences in the absence and presence of ETS1 (ns = non-
significant, ** = t-test P < 0.01). (e) 1H–15N HSQC spectra focused on K192N-H NMR titration peak for FOXO1 
with increasing DNA concentration of ω-none, ω and ω-high. Colors indicate DNA to protein concentration 
ratios. Fast to intermediate regime change in titration peak for ω-high highlights cooperativity. (f) Titration 
curve of FOXO1 binding to ω-high using K192N-H peak, without (gray dots), and with ETS1 (red dots). Gray 
line indicates titration fit without ETS1. 
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2.2.4. Quantitative modeling reveals structural insights into DNA-ternary 
complexes 
Based on the above observations we wanted to gain more structural insights into the 
cooperative Forkhead-Ets interaction as well as other TF pairs. So far, we showed that 
DNA shape features are important to predict binding of TF pairs (Fig 2.1c), and that, in the 
case of FOXO1:ETS1, differences between high- and non-cooperative DNA sequences were 
locally restricted (Fig 2.2c). We therefore hypothesized that position-specific DNA shape 
features may determine the cooperativity potential of DNA sequences. To test this, we used 
our quantitative modeling framework to calculate the importance of DNA shape features at 
each position along the composite motifs for all TF pairs in the CAP-SELEX data. 
Specifically, we compared models with and without all DNA shape features at a given 
position, and reported the maximum ΔR² per position, adapting an approach developed by 
[Yang et al. 2017] (Appendix A). For each composite motif, we thereby obtained a “shape 
profile” that captures the importance of DNA shape at each position for predicting the 
relative affinities of a TF pair (Fig 2.3a; benchmark with HT-SELEX data in Fig S2.5). 
To globally explore the positional effects of shape profiles, we scaled them to the same 
length and grouped them into five groups using unsupervised clustering (Fig 2.3b; Fig 
S2.5a; Appendix A). All clusters are characterized by a single peak in the shape profile, 
indicating that the effect of DNA shape is localized to a specific region along the protein-
DNA interface. We observed a significant enrichment of TF pairs containing Forkhead 
members in cluster 1 (odds ratio=3.1, adjusted P value < 0.1, Fisher’s exact test). Other TF 
families and TFs were specifically enriched in other clusters (Fig S2.5b). This result 
indicates that some TF families have a conserved preference for shape or high-order 
features when interacting with other TFs. Interestingly, shape profiles for pairs that 
include Forkhead members in cluster 1 peaked at the Forkhead binding site (Fig 2.3c). 
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Together with the results from the previous section, this suggested that shape readout at 
the Forkhead region might guide the cooperative interaction between Forkhead and 
partner TFs. This mechanism was further supported by comparing the shape profiles of 
exemplary Forkhead-Ets TF pairs with the profiles of single Forkhead and Ets TFs, 
obtained from HT-SELEX: While FOXO1 by itself still showed a higher shape preference 
than its Ets partner, the maximum value of the profile was shifted by at least three 
positions relative to the one of the TF pair. Similarly discrepant patterns between single 
and composite profiles were observed for other Forkhead members such as FOXI1 with Ets 
TFs (Fig S2.3d-e). These results suggest that the shape profiles are likely related to 
Forkhead-Ets cooperative binding for many members of the respective families, and 
unlikely due to individual TF binding. 
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Figure 2.3. Clustering of shape improvements by position in CAP-SELEX data reveal combinatorial TF 
binding shape-recognition biases. 
(a) (top) Scheme describing shape profiles calculation. For a homo- or heterodimeric protein-DNA complex, shape 
features are individually added to assess their relative contribution to the global increase in performance. 
Averaged contributions are transformed by interpolation to a curve representation. (Appendix A) (b) (left) PAM 
clustering of shape profiles across all CAP-SELEX models analyzed. Each row shows a composite motif (N=438). 
Five representative clusters are separated by red lines. (right) Average shape profiles for each cluster. Blue shades 
indicate one standard deviation. Enrichments for TF families within clusters are labeled (OR=odds ratio). (c) (top) 
Forkhead-Ets FOXO1:ELK3 motif, (bottom) ΔR2p  changes (as percentages) in FOXO1:ELK3 CAP-SELEX data (blue 
line). Additional lines indicate equivalent values for FOXO1, and ETS1, an ELK3 paralogue (green and orange, 
respectively) calculated from HT-SELEX [Jolma et al. 2013]. Error bars indicate windowed average standard 
deviation, with window value of 4. (d) (top) ΔR2 per position changes are shown for selected CAP-SELEX data that 
contain FOXO1 in combination with other binding partners of similar binding topology. IUPAC DNA symbols in 
heatmap indicate aligned k-mers. (bottom) Column averages for heatmap values. Error bars indicate standard 
deviations in each position. (e) FOXO1-ETS1 ternary complex. ETS1 residue R409 interacting with DNA minor 
groove is highlighted in a red box (PDB ID: 4LG0). Visualization was enhanced by PDIviz [Ribeiro et al 2015]. (f) 
Dissociation constant measurements using ITC for FOXO1 binding to ω DNA sequence upon addition of ETS1 wild 
type and selected mutants (* indicate adjusted P values obtained using two sided t-test) 
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2.2.5. Site-directed mutagenesis reveals ETS residue R409 as driver of 
cooperativity 
Given that the shape profiles were highly conserved across many members of the Forkhead 
and Ets families (Fig 2.3d), we wanted to investigate whether protein-DNA interface 
properties at the peak of the profile may confer cooperativity. Through assessment of the 
available crystal structure for FOXO1:ETS1 bound to DNA, we observed an arginine residue 
(R409) of ETS1 interacting with the minor groove at the position with highest shape 
relevance of the FOXO1 binding site (Fig 2.3e; PDB ID: 4LG0) [Choy et al. 2014]. This agrees 
with the high relevance of Minor Groove Width features for binding prediction in our 
models (Fig S2.5c). Given the strong conservation of positively charged residues in this 
position across Ets family members (94%; Appendix A), we hypothesized that the DNA-
cooperativity between Forkhead and Ets is mediated by this residue. 
To test this, we performed site-directed mutagenesis of the ETS1-residue in question 
(R409) and monitored the changes in the dissociation constants of FOXO1 for one of our 
previously validated cooperative DNA sequences (ω) using ITC (Fig 2.3f; Appendix B). 
Replacement with alanine (R409A) significantly reduced the cooperative effect between 
ETS1 and FOXO1 with a significant drop in binding affinity of FOXO1 to ω relative to wild 
type ETS1 (Kd = 151 ± 11 nM in R409A vs 44 ± 11 nM in WT; P = 2.4 x 10-3). In contrast, 
replacing the arginine with another positively charged residue (Histidine; R409H), 
resulted in a FOXO1 binding affinity similar to wild type ETS1 (Kd = 67 ± 4 nM) thus 
retaining the cooperative interaction. To study whether this effect solely depends on that 
specific residue, we tested a neighboring residue (Y410A), and observed almost no changes 
in FOXO1 affinity (Kd = 313 nM; Fig S2.5f). We concluded from these analyses that the 
cooperativity between FOXO1 and ETS1 is indeed mediated by the interaction of R409 of 
ETS1 and the DNA minor groove opposite the FOXO1 binding site. As the affinity of FOXO1 
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in presence of the mutant ETS1 was still higher than for FOXO1 alone, we cannot exclude 
that other residues may also contribute to the cooperativity. 
2.2.6. Cooperativity between Ets and Forkhead determined in vitro is relevant in 
vivo 
Having demonstrated, mechanistically analyzed, and experimentally validated 
cooperativity between members of the Forkhead and Ets TF families in vitro, we next 
wanted to assess whether these findings can be translated to in vivo systems based on 
ChIP-Seq data and whether TF-TF interactions can aid in explaining TF binding events.  
We first tested whether DNA shape was equally important for predicting co-occupied 
ChIP-Seq regions as it was for predicting cooperative binding based on CAP-SELEX data. 
To do so we used a classification framework similar to [Mathelier et al 2016], to compare 
models based on motif match (PWM) only and motif match plus DNA-shape features 
(PWM+shape) for predicting co-occupied ChIP-Seq regions between pairs of TFs 
(Appendix A). Overall, we obtained similar results as for the in vitro data with 105 peak sets 
showing improved classification performance after addition of shape features in mapped 
TF cooperative sites (P < 0.0001; one-sided Wilcoxon rank-sum test) (Fig 2.4a). In 
agreement with the in vitro data analyses, TF pairs that include a Forkhead family member 
particularly benefited from DNA shape (P = 0.03; one-sided Wilcoxon rank-sum test) (Fig 
2.4b). 
When comparing the shape profiles obtained from the in vivo and the in vitro data 
(Appendix A), we observed a strong agreement for 40% of them (FDR = 10%) (Fig 2.4c); 
median spearman correlation = 0.25). This suggests that DNA shape plays a similar role in 
driving cooperativity in vivo for specific TF pairs. Among the correlated profiles were 
several Ets-Forkhead pairs e.g. FOXO1:ETV4 (Fig 2.4d). 
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We next wanted to assess to which extent Forkhead:Ets members bind cooperatively 
versus non-cooperatively in vivo. To do so, we calculated the enrichment of the ω and ω-
none motifs in co-occupied ChIP-Seq data for members of both Forkhead and Ets families 
- assuming that the FOXO1:ETS1 ω and ω-none k-mers are representative of other 
Forkhead-Ets members (Appendix A). We found both ω-none and ω enriched among the 
co-occupied regions of the 126 TF pairs using the single occupied regions as background 
(Fig 2.4e). 18 TF pairs showed enrichment for both the non-cooperative as well as 
cooperative sequences (ω-none and ω) confirming the co-existence of cooperative and 
non-cooperative binding patterns between the same pairs of TFs in vivo. Another 29 pairs 
were only enriched for either cooperative or non-cooperative sequences (5 and 24 
respectively). These results suggest variable degrees of cooperativity between Forkhead-
Ets TF pairs, thus hinting at a TF-pair specific cooperativity, which adds an additional 
layer of regulatory complexity in vivo. 
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Figure 2.4. Cooperative TF binding agreement between SELEX and in vivo data. 
 (a) Classification performance comparison between PWM+shape (y-axis) versus PWM models (x-axis) in regions 
that were selected for being co-bound by ChIP-seq for TF pairs present in CAP-SELEX data (N=105). Classification 
performance is measured by the Area Under The Receiver Operating Characteristic Curve (ROC-AUC). Blue points 
indicate TF pairs with Forkhead as one of its members. (b) ROC-AUC differences between classification models for 
datasets containing at least one Forkhead member (blue) and all other TF pairs (pink). P value obtained using 
Wilcoxon rank-sum test. (c) Spearman correlation distribution of performance changes per position in in vitro (R2), 
and in vivo (ROC-AUC) between matched TF pairs. Orange line indicates FDR 10% cutoff for positive correlations (d) 
(top) Forkhead-Ets composite motif model between FOXO1 and ETV4, (bottom) aligned performance changes per 
position observed in in vitro (CAP-SELEX; red line) and in vivo (ChIP-seq; blue line). ρ indicates effect size. (e) (top) 
Scheme illustrating co-enrichment calculations for ChIP-seq regions co-occupied between Forkhead and Ets 
versus single TF occupied. (middle) Dot plot showing ω-none and ω k-mer enrichments between co-occupied and 
single TF peaks (Adjusted P value obtained from a Fisher’s exact test between fraction of regions with motif in co-
occupied peaks versus fraction of region with motif in single TF occupied peaks) (bottom) Venn diagram indicating 
significant observation for tested k-mers, and number of datasets with enrichments for both. 
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2.2.7. Inference of TF-phenotype associations using TF-cooperativity k-mers 
Having shown that cooperativity is both prevalent and specific in vivo we further 
investigated its potential functional impact. We first wanted to assess whether certain 
biological processes are specifically regulated by cooperative TF binding. To do so, we 
assumed that genes regulated by a pair of TFs should reflect biological functions common 
to both TFs and that these functions should be captured by gene ontology terms. Further, 
we defined TF-pair-to-gene links by mapping regions co-occupied by both TFs (using 
ChIP-Seq from ReMap [Cheneby et al 2018]) to target genes (using GREAT [McLean et al 
2010]; Appendix A). 
With this, we devised an “Ontology Association Probability” that quantifies relationships 
between each TF pair and an ontology term using logistic regression. Briefly, for each TF 
pair we modeled their membership in a given ontology term based on the number of their 
target genes and regulatory elements (normalized as z-scores) mapped to it (Fig 2.5a; 
Appendix A). To test the effect of cooperativity on the ontology association probability we 
compared models with only ChIP-Seq data as features (“peaks”) to models with only 
cooperativity k-mers (“k-mers”) and models using both (“peaks+k-mers”). For all models, 
we observed higher association probabilities for ontology terms annotated to the TF pair 
(“TF1 and TF2”) than for random background terms (P < 0.001; Wilcoxon one-sided test) 
(Fig 2.5b). The highest associations were obtained for models considering genes regulated 
by cooperatively bound peaks (peaks+k-mers; P < 0.01), emphasizing the role of TF 
cooperativity in regulating specific processes. 
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Figure 2.5. Inference of TF-phenotype associations using TF-cooperative k-mers. 
 (a)  Scheme illustrating calculation of Ontology Association Probability values using TF-TF k-mers, ChIP-seq 
data and ontology databases. For each TF-pair and ontology combination, four metrics describing the numbers 
of genes and peaks proximal to the ontology-related genes are converted into Z-scores (Appendix A). From 
peaks assigned to for both TFs (TF1ՍTF2, gray oval), the sub-selection using the co-occupied peaks (TF1∩TF2, 
blue oval; features 1 and 2) allows calculating Ngene and Npeak, and co-occupied peaks with TF-TF k-mers allow 
calculating Ngene,k and Npeak,k (green oval; Features 3 and 4). Ontologies are labeled by the presence of both TFs 
(TF1 and TF2), one (TF1 or TF2), or none (background) in the ontology. Models with different combinations of 
features are tested (peaks = 1 and 2. (Blue); k-mers = 3 and 4. (Green); peaks+k-mers = 1, 2, 3 and 4. (Red)). (b) 
Distributions of association probabilities for Human Phenotypes Ontology (HPO) terms for terms labeled as “TF 
and TF2” versus background terms are shown (* indicate Wilcoxon rank-sum test P values). (c) Classification 
task performances in the assessment of “TF1 and TF2” versus “background” terms in three ontology databases. 
ROC-AUC and PR-AUC indicate areas under the ROC and Precision-Recall curves. P values are derived from 10-
fold cross validation metrics comparisons between peak+k-mers and reference approaches using an independent 
t-test, after Benjamini-Hochberg correction. 
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We next sought to use the derived metric for discovering biological functions of 
cooperatively bound TFs. In particular, the association probability can be used to predict 
ontology terms of all TF pair combinations (Appendix A). Using defined ontology terms 
common to both TFs as a gold standard, performance metrics indicated that predictions 
were on average better when using peaks+k-mers versus peaks or k-mers. This was the 
case in three tested ontology databases (GO; DISEASES; HPO) [Ashburner et al 2000; The 
Gene Ontology Consortium 2019; Köhler et al 2018; Pletscher-Frankild et al 2015] and 
irrespective of the performance metric (mean ROC-AUC = 0.70 (peaks+k-mers), 0.61 
(peaks), and 0.64 (k-mers) (P = 6.7 x 10-8); mean Area under the Precision-Recall Curve 
(PR-AUC)) = 0.18, 0.15 and 0.06 (P = 2.3 x 10-9)) (Fig 2.5c). Interestingly, the classification 
performance of ontologies related to both TFs is higher than the one where only one TF of 
the pair is associated to the ontology (“TF1 or TF2”; mean ROC-AUC = 0.66; mean PR-AUC 
= 0.14; Fig S16a). These results indicate that processes cooperatively regulated by two TFs 
can be distinguished from those regulated by each TF individually. 
To capture the strongest associations between TF pairs and terms across all used ontology 
databases, we defined a model-dependent signal-to-noise threshold on the association 
probabilities (Appendix A); this recovered 6600 strong associations with high 
probabilities and both TFs as members of the ontology (Fig S2.5b). We considered this 
number an underestimate limited by the availability of ChIP-Seq data since applying a 
variation of our model using only TSS k-mers identified cooperative TFs interacting with 
partner TFs in cell differentiation and disease (Fig S2.5c) that for which no ChIP-seq 
exists. Following up on our previous results we focused on Forkhead-Ets pairs and 
recovered strong associations between specific partners and ontology terms for 20 of them 
(Fig 2.6a). FOXO1 showed the highest number of associations with different TFs (nine), 
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suggesting a multifunctional role for this TF through cooperative interaction with multiple 
partners. FOXO1 was most strongly associated with sarcoma (DOID:1115, with ELF1), and 
squamous cell carcinoma (DOID:5520, with ELF3) (k-mer = WAAACAGGAAG for both 
terms; average k-mers z-score > 5). This is in agreement with previous reports proposing 
FOXO1 as a prognostic marker in sarcoma [Zhang et al 2009]. Moreover, ELF3 has been 
proposed as a marker in squamous cell carcinoma [AbdulMajeed et al 2013] and ELF 
members have been generally recognized to play a role in sarcomas [Ando et al 2016]. In 
light of these results and their strong agreement with the literature, we hypothesized that 
expression levels of FOXO1 together with predicted TF partners could be a potential 
readout to interrogate clinical cancer data. 
We examined this concept using available data on lymphoid leukemia patients to examine 
the effect of predicted associations with cooperative binding of FOXO1 and ETV6 
(DOID:0050745, k-mer GAAAACCGAANM; mean k-mers z-score = 3.2). Specifically, we 
stratified patients in a Chronic Lymphocytic Lymphomas (CLL) cohort [Dietrich et al. 
2018] into high/low expression levels for both TFs (Appendix A), to explore their usage as 
prognostic markers. Strikingly, we obtained a significant increase in overall survival when 
both TFs were highly expressed (Hazard Ratio (HR)=0.21, 95% CI 0.10-0.45; P = 6.5 x 10-5) 
(Fig 2.6b). This association was not found when considering each factor separately, and it 
was not confounded by p53 and IGHV mutation statuses (HR=0.19, 95% CI 0.07-0.48, P = 
5.0 x 10-4, Fig S2.5d). Importantly, this is the strongest association to survival among all 
FOXO1-Ets combinations, for which ChIP-seq data was available. Together with reports of 
FOXO1 and ETV6 as putative tumor suppressors in lymphomas [Xie et al. 2012; Peker et al. 
2013] this suggests an important role of this TF pair in lymphoid leukemia. 
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Overall, our results demonstrate the increased power of cooperative TF-binding models 
applied to in vivo data for an unbiased screening of novel TF pairs as potential drivers of 
function and disease. 
 
 
Figure 2.6. Forkhead-Ets cooperativity related association to function and disease 
(a) Strong associations networks between Forkhead-Ets families using HPO and DISEASES ontologies 
(Appendix A). Nodes indicate TFs and edges indicate ontologies names. Edge width indicates relevance of 
features 3 and 4 the final association probability value (COPD=Chronic obstructive pulmonary disease; 
T2D=Type 2 Diabetes) (b) (top) Cartoon describing association between Forkhead+Ets k-mer 
GAAAACCGAANM and lymphoma associated genes through intersected peaks. (middle) Kaplan-Meier plot of 
overall survival in CLL patients when using FOXO1 and ETV6 expression medians (“high/low” defined as 
above/below median, and labeled as + and -, respectively). P-values are derived from two-sided log-rank 
comparison with respect to -/- expression levels for both FOXO1 and ETV6 (data from [Dietrich et al. 2017]). 
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2.3. Discussion 
Here we provide a novel framework to study different types of TF binding data for single 
and co-binding TFs in vitro and in vivo, allowing to systematically gain structural insights 
into TF cooperative binding, and revealing their functional and disease-related relevance. 
Statistical learning proved to be an integral part to understand the contributions of DNA 
features to TF binding, such as in approximating positional relevance of nucleotide 
interactions and DNA-shape features in TF binding models. Thereby our models provide a 
platform for generating hypotheses about the possible consequences of disruptions in 
DNA-shape readout [Slattery et al. 2011; Yang et al 2017, Kribelbauer et al. 2017, Rube et 
al. 2018]. Importantly, applying those concepts to cooperative TF binding data, we derived 
specific and conserved binding preferences across TF families. Using FOXO1 and ETS1 as 
representative members of the Forkhead and Ets families, we demonstrated that such 
conserved TF-interactions are clearly linked to DNA-shape readout with stronger effect 
sizes than the ones for homeodomain pairs [Slattery et al 2011]. We reinforced this 
argument by identifying a conserved residue that mediates cooperativity in Ets family 
members. This particular arginine residue happens to harbor multiple DNA-binding 
domain polymorphisms [Barrera et al. 2016], suggesting that the extent of this particular 
cooperativity between Forkhead-Ets members can be prone to variation across healthy 
individuals. 
Our work presents a major methodological advance over recent studies on the quantitative 
assessment of DNA-shape readout and its contribution to TF binding, which are limited by 
data sparsity due to long binding (composite) motifs. To estimate feature preferences for 
such motifs, we introduced a “trim-and-summarize” approach allowing the reliable 
quantification and comparison between models considering motifs spanning a mean of 18 
base pairs in CAP-SELEX data from Jolma et al. (Appendix A). Given the reasonable 
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agreement of our results with in vivo data, this approach could prove useful in integrating 
low-coverage SELEX data with other studies of higher data quality [Zhang et al 2018; 
Rastogi et al 2018], as well as screening for novel cooperative TF binding sites in vivo. 
TF binding has been associated to chromatin regulation [Grubert et al 2016] and disease 
[Deplancke et al 2016], yet cooperative binding has not been systematically analyzed in 
such contexts. The knowledge of TF-TF allostery can be used to predict co-occupied TF 
regions and annotate cryptic binding sites [Narasimhan et al 2015]. As genetic disruptions 
in such TF-cooperativity regions are important to understand failures in developmental 
programs [Slattery et al 2011] and disease [Iwata et al 2017], there is a requirement for 
models that predict preferences for TFs acting in combination and the functional 
consequences of such events. Here, the integration of cooperative TF k-mers with ontology 
associations of TFs allowed us to thoroughly examine potential functional consequences 
stemming from genome loci targeted by cooperative TF-binding. Although other studies 
have associated composite motifs to specific cell types using in vivo data before [Jankowski 
et al. 2014; Guturu et al. 2013], we successfully demonstrate that incorporating a new layer 
of knowledge on the degree of cooperative binding gives a significant leverage in 
identifying biological processes specific to TF pair binding. In fact, the knowledge of 
cooperative k-mers translates into better TF-ontology predictions and could thus increase 
the extent of our functional knowledge on cooperative TF binding and its underlying 
biology (Fig 2.7). Importantly, we release our current predictions for community 
examination of new mechanistic interactions between TF pairs. 
Given the considerable amount of strong associations between TF pairs and disease, the 
clinical power of revealing such functional connections in a systematic manner is not to be 
underestimated. Our investigation of the TF pair FOXO1:ETV6 and its cooperativity-driven 
association with overall survival in CLL exemplifies this clearly and is reinforced by the 
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observation of a FOXO1/ETV6 gene fusion in leukemia patients [Stengel et al 2018]. Both 
FOXO1 and ETV6 have been described as putative tumor suppressors in lymphomas [Xie et 
al. 2012; Peker et al. 2013], yet the extent of the cooperativity-driven functional impact in 
Leukemia relative to other FOXO1-Ets combinations has not been understood nor 
quantified. Future work will be required to understand whether this particular mechanistic 
relationship occurs prior or after FOXO1 mutations [Trihn et al 2013] or whether it 
represents an independent event in cancer progression in the first place. Systematic 
modeling of such associations and their network interdependencies remains, however, an 
indispensable component in leveraging TF cooperativity for functional interrogation and 
prioritization of disease-related TF combinations. 
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Figure 2.7. Model to estimate cooperative TF-binding contribution to TF-ontology associations. 
(top) Illustration of different types of models that describe associations of TF with function and disease. The 
Standard model describes the contribution of single TF-DNA binding, which can be improved by the addition 
of TF-TF interactions for an enhanced understanding of function and disease. This is translated into an 
overall increased discovery of strong phenotypes associated to TFs when acting in combination. (bottom) 
Information used in this work to describe TF cooperativity and reveal TF-cooperativity linked processes 
(DNA-mediated cooperativity = TF-TF k-mers and prioritization of important binding modes; ChIP-seq = 
co-occupied peaks for TF pairs; ontologies and TF-gene pairs = associations between co-occupied regions by 
TF pairs and their associated genes, linked to function through ontology data).  
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Chapter 3 
 
BDNF promotes enhancer accessibility essential for gene 
activation and exon usage in neurons 
 
In this chapter, I describe the analyses and results of a collaboration project that explores the 
molecular response of mouse cortical neurons by multi-omics data integration. Methodologies 
and experimental data generation behind this work have been initially conceived by Vikram 
Ratnu, in a collaboration between the groups of Kyung Min Noh and Judith Zaugg at EMBL 
Heidelberg. I carried out all computational analyses and suggested further validation 
experiments that were part of the results sections. The work has been described in the following 
manuscript: 
Ignacio L. Ibarra*, Vikram S. Ratnu*. Lucia Gordillo, Luca Mariani, Katy Weinand, 
Martha L. Bulyk, Judith B. Zaugg & Kyung-Min Noh (2019). BDNF promotes enhancer 
accessibility essential for gene activation and exon usage in neurons. In preparation. 
 
 
  
50 
 
3.1. Introduction 
How neuronal activity is linked to function of the nervous system is a question of 
paramount importance in neuroscience. Molecular mechanisms regulating synaptic 
transmission and plasticity have been intensely studied for decades, and their relevance is 
acknowledged as their functional deficits can lead to neurogenetic disorders, linked to 
learning and behavior on many levels [de la Torre-Ubieta et al 2018]. 
It has been understood that neuronal activity is mainly determined by changes in gene 
expression patterns, which is tightly regulated at the genome level through epigenetic and 
accessibility markers [Peixoto et al 2012]. Multiple studies have assessed the impact of 
such markers on neuronal activity and their species-wide conservation as a way to 
prioritize regions related to developmental and intelligence disorders [Reilly et al 2015]. 
However, studies focusing on the link between genome-wide accessibility changes and 
gene expression programs at intermediate and late time points after neuronal stimulation 
are lacking. Nor has it been shown how different stimuli confer specific neuronal activity 
by differentially impacting the accessibility and gene expression landscape. 
Here we present a study that profiles both accessibility and gene expression changes in a 
genome-wide manner to identify features that determine mouse cortical neuron response 
to stimuli. Through joint temporal profiling of chromatin accessibility and gene expression 
upon three stimuli (BDNF, KCl and Forskolin) in mouse primary cortical neurons, we 
delineated molecular rules determining chromatin-to-expression programs. Our genome 
wide analysis pointed at regulatory factors mediating neuronal response to our stimuli in a 
shared and treatment-specific way, allowing us to identify the underlying mechanisms as 
well. Specifically, we found and validated an axis between co-regulators and co-repressors 
controlling the expression response in BDNF, whereas the neuronal response upon KCl 
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stimulation was mostly determined by an interplay between CTCF and accessibility-
mediated transcriptional changes.  
3.2. Results 
3.2.1. Stimulus specific biphasic transcription in response to neuronal activity 
We investigated how different neuronal stimuli (BDNF, KCl, Forskolin) impact gene 
expression programs in mouse primary cortical neurons. BDNF activates p75NTR and Trk 
receptor tyrosine kinases which trigger signaling pathways involved in neuronal plasticity 
[Chao et al 1995; Poo et al 1991]. KCl (55 mM) induces membrane depolarization, calcium 
influx [Greer et al 2008], and calcium-dependent signaling pathways leading to changes 
in gene expression. Forskolin increases secondary messenger cAMP by activation of 
adenylate cyclase [Seamon et al 1981]. As KCl is well characterized for neuronal activity in 
vitro [Bading et al 1993, Macias et al 2001], we compared it with concentrations of BDNF 
(5, 10 and 20 ng/mL) and Forskolin (5, 10 and 20 µM) by immunoblotting serine 10 
phosphorylation of histone H3 (H3S10P) (Appendix B), a marker for neuronal activity 
[Wittmann et al 2009]. H3S10P levels were higher in Forskolin than BDNF and KCl (Fig. 
3.1a), but concentrations of BDNF and Forskolin have a similar impact. Thus, we used an 
intermediate dose of Forskolin (10 µM) and BDNF (10 ng/mL) for further experiments. 
We analyzed the gene expression from RNA-sequencing (RNA-seq) at three time points (1, 
6, and 10 hours) and at each time the three stimuli (BDNF, KCl, Forskolin) were compared 
to matched controls (Fig. 3.1a; Appendix A and B). Hierarchical clustering of log2 fold-
changes of all differentially expressed genes (DE-genes) in all the conditions (FDR=10%) 
revealed that after 1h similar DE-genes are induced upon BDNF and Forskolin treatment. 
At later time points (6 and 10h), however, DE-genes are clustered by individual treatment 
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(Fig 3.1b; Appendix A). The total number of early DE-genes varied across treatments with 
a majority of them induced by KCl, followed by BDNF and Forskolin (Fig 3.1c). Treatment 
differences emerged when DE-genes were annotated by their first appearance (“new DE-
genes”). We observed a decreasing number of new DE-genes at each time point for BDNF 
(3201, 2597, 722) and KCl (5352, 4344, 905), whereas Forskolin showed a peak of new DE-
genes at 6h (458, 1570, 548). These results indicate that major transcriptional changes for 
all treatments occur at 1h and 6h, and BDNF and KCl share common transcriptional 
dynamics despite the higher similarity between BDNF and Forskolin at 1h (Fig 3.1b). As 
lower levels of H3S10P are observed in BDNF and KCl compared to Forskolin, these results 
also indicate that H3S10P levels alone do not fully capture the transcription response.  
Given the dynamics of gene expression at 1 and 6 h, we sought to assess the biphasic 
transcription, a key feature of neuronal activity-induced transcription which comprises 
immediate early genes (IEGs) e.g., transcription factors and delayed response genes 
(DRGs) involved in synaptic plasticity and neuronal function [Flavell et al 2008]. Using 
unsupervised clustering of the topmost 5000 significant DE-genes across treatments and 
time points (Appendix A), we observed that BDNF and KCl show distinct early and late 
gene clusters (Fig. 3.1d). For example, IEGs expression is divided for BDNF (cluster 1; Arc, 
Egr2) and KCl (cluster 3; Npas4, Fosb). At late time points (6h and 10h), upregulated genes 
are separated for BDNF (cluster 2) and KCl (cluster 4, 5 and 6). Cluster 2 includes known 
neuronal function related genes (Bdnf, Cebpb). Clusters 4, 5 and 6 contain many solute 
transporters and ion channel related genes (Slc43a2, Cacna1d, Slc25a25, Kcne4 etc.) 
[Tyssowski et al 2018]. In contrast to upregulation, early downregulated genes are 
prevalent in KCl (cluster 8), whereas several clusters of late down regulated genes appear 
in BDNF (cluster 7) and KCl (clusters 9 and 10). Gene ontology (GO) analysis for individual 
clusters (Fig. 3.1e) shows that early induced gene clusters for both up (1, 3) and down (8) 
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regulated genes are enriched with TFs, regulation of transcription, and DNA binding. Late 
clusters (2, 4, 5 and 6) showed enrichment for different types of ion channels and 
transporters for BDNF and KCl. The expression of different transporters may contribute to 
the electrical diversity in neurotransmission between treatments [O'Rourke et al 2012]. 
For BDNF, late downregulated genes (cluster 7) are also enriched for TF activity and DNA 
binding terms, whereas for KCl (clusters 9 and 10) are enriched for neurological and cell 
division related terms. 
Altogether, our results reveal cortical neuronal activity differences across stimuli, at the 
level of gene expression, both in dynamics and in terms of activated and repressed 
functions. 
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Figure 3.1. (legend on next page) 
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Figure 3.1 Differential expression dynamics in mouse cortical neurons upon neuronal activity. 
(a) (top) Experimental setup. Cultured cortical neurons are stimulated with different treatments and prepared at  
three specific time points for joint RNA-seq and ATAC-seq. (bottom) Histone mark phosphorylation H3S10P for 
Forskolin, KCl and BDNF (Con = no stimulation). Actin is shown as internal control. (b) Clustering of correlations 
calculated from log2 fold changes (versus control samples) of all DE-genes (differentially expressed genes). (c) Bar 
plots indicate the number of DE-genes at each time point and treatment combination (above X-axis = up-
regulated; below X-axis = down-regulated). For time points 6 and 10h the lined box indicates the number of newly 
acquired DE-genes that did not appear in a previous time point. (d) Unsupervised clustering of differential 
expression changes (FDR=10%, n=5000). 10 clusters resulted from the row mean Z-scores calculated from 
expression values. (e) Ontology term enrichments for clusters shown in (d). 
3.2.2. Stimulus specific chromatin accessibility upon neuronal activity  
Chromatin remodeling tightly controls gene expression [Gallegos et al 2018]. Using the 
Assay for Transposase-Accessible Chromatin sequencing (ATAC-seq), we quantified the 
chromatin accessibility differences between stimuli at all the time-points (Fig.3.1a; 
Appendix A). Hierarchical clustering of the log2 fold changes of 15566 differentially 
accessible peaks obtained in all conditions with control comparisons (DA-peaks, 
FDR=10%) (Fig. 3.2a; Appendix B) revealed that, unlike DE-genes where samples did not 
cluster by treatment at early time, DA-peaks always clustered in a treatment specific 
manner (Fig. 3.2a). When we further classified DA-peaks into gained and closed peaks 
(log2 fold changes greater and lower than zero, respectively), we observed for BDNF the 
maximum number of DA-peaks at 1h, followed by KCl and Forskolin (9012, 3701 and 373 
respectively) (Fig. 3.2b) which is different to the RNA-seq result that shows a maximum of 
DE-genes at 1h KCl. This result implies that the genome response through accessibility 
changes is stronger in BDNF than KCl. Similar to DE-genes we annotated DA-peaks by 
being firstly observed as DA-peaks in specific time points (“new DA-peaks”) and found 
them consistently decreased for BDNF, but not for KCl. The high number of late DA-peaks 
in KCl is explained by a higher fraction of newly gained DA-peaks at both 6h (1551, 71.5%) 
and 10h (1025, 47.3%) relative to 1h (2168). In comparison, BDNF response displays a much 
smaller fraction of newly gained DA-peaks at 6h (446, 6.9%) and 10h (418, 6.5%) versus 
1h (6379). For closed DA-peaks, we observed a similar pattern for both BDNF and KCl, with 
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decreasing numbers from early to late time points, and comparable fractions of new closed 
DA-peaks (Fig. 3.2b). These results show that chromatin changes induced by BDNF are an 
early event, while KCl exhibits similar levels of chromatin response at late time points. As 
the low number of DA-peaks obtained for Forskolin limited analysis, we henceforth 
focused analyses on BDNF and KCl. 
To define the genome wide distribution of activity-induced accessible chromatin regions 
we annotated gained and closed DA-peaks to their genomic features using Homer [Heinz 
et al 2010] (Appendix A). The DA-peaks were distributed in the three topmost categories 
e.g., intergenic regions, introns, and gene promoters (Fig 3.2c; Fig S3.3a), but more 
intergenic DA-peaks observed in BDNF (45%) than KCl (40%), and more promoter DA-
peaks for KCl (20%) than BDNF (5%). Widespread intergenic DA-peaks for BDNF suggest 
that its main chromatin accessibility changes occur at distal regulatory elements (DREs). 
Increased promoter DA-peaks for KCl imply a rapid gene expression response, which is in 
agreement with the greater number of DE-genes found in KCl at 1 h (Fig 3.1c). We further 
defined the epigenomic states of the DA-peaks using a chromatin states model from adult 
mouse neurons generated with Chromatin Immunoprecipitation followed by Sequencing 
(ChIP-seq) data (Fig 3.2d; Fig S3.3b) [Su et al 2017]. In KCl, gained and-closed regions 
often appeared at active TSS and bivalent promoters and were co-marked by active histone 
marks H3K4me1, H3K27Ac and H3K4me3. Early closed DA-peaks showed a specific 
enrichment for CTCF (Fold Enrichment = 8.1) (Fig 3.2d). In BDNF, gained and closed DA-
peaks showed enrichment for active TSS, downstream of TSS and gained enhancers, co-
marked by active histone marks H3K27Ac and H3K4me3. Moreover, moderate enhancers 
and enhancers within a gene are enriched for BDNF closed and gained DA-peaks, 
respectively (Fig. 3.2d). Thus, accessibility changes in DREs are more prevalent in BDNF 
than KCl. Ontology analysis revealed a strong association to abnormal associative learning 
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in both BDNF and KCl DA-peaks. Additionally, peripheral nervous system and potassium 
channel activity terms were enriched more for BDNF gained DA-peaks, while abnormal 
peripheral nervous system synaptic transmission was enriched for KCl gained DA-peaks at 
1h (Fig. 3.2e). Altogether, our analyses show wide differences in chromatin response 
between BDNF and KCl, which connects activity-dependent gene expression to their 
signature responses. 
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Figure 3.2. (legend on next page) 
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Figure 3.2 Variation in chromatin accessibility shows early neuronal activity specificity in BDNF- and KCl-
treated samples.  
 (a) Clustering of correlations from log2 fold changes of all DA-peaks (differentially accessible peaks) versus 
control samples. (b) Bar plots indicate the number of DA-peaks at each time point and treatment combination 
(above X-axis = gained; below X-axis = closed). Newly gained and closed peaks at 6 and 10 h are highlighted 
by lined boxes. (c) Percentage of DA-peaks with HOMER genomic annotations at 1h (d) Log2 fold enrichments 
for ChromHMM neuron chromatin states. (left) Emission scores and state names; (middle) log2 fold 
enrichments of gained DA-peaks. Lined boxes indicate time point with greatest fold enrichment value. Bar 
plot compares BDNF versus KCl maximum values. (right) Log2 fold enrichments of closed DA-peaks. (e) Log2 
odd ratios for gained and closed DA-peaks related to ontology terms scored using GREAT. (f) Cumulative 
distributions for log2 fold changes next to TSS related genes. (g) (top) Association between DREs and gene 
expression at BDNF 1h. Each point indicates the log2 fold change of an ATAC-seq derived peak and its linked 
gene expression as log2 fold changes. Colors indicate whether none, only the peak, or both peak and gene 
(red) show significant changes (bottom). Enrichment for DA-peaks and DE-genes in the four quadrants are 
summarized for BDNF and KCl. Asterisks indicate adjusted P value obtained from Fisher’s exact test, and 
corrected by Benjamini Hochberg procedure. 
3.2.3. Coordination between expression and accessibility between proximal distal 
regulatory elements and their target genes 
We investigated the dependencies in changes between chromatin accessibility and gene 
expression upon neuronal activity by determining the global correlation between putative 
DRE associated peaks and their proximal genes for BDNF and KCl at all time-points 
(Appendix A). The highest coordination was observed between gained DA-peaks and 
upregulated DE-genes in BDNF at 1h (odds ratio = 5.8; P < 0.0001), without any 
significance in other comparisons and in KCl at 1h (odds ratio = 1.1; P > 0.05). At 6 and 10h 
we observed significant coordination between gained DA-peaks and gained DE-genes for 
both BDNF and KCl (Fig. 3.2f). These results indicate that for BDNF the chromatin DREs 
affect gene expression starting at 1h, while for KCl the coordination occurs later. 
Co-variation of DREs such as enhancers and their target promoters can occur due to their 
physical proximity and the formation of physical contacts [de la Torre-Ubieta 2018]. 
Using our ATAC-seq data, we calculated the correlations between accessible DREs and 
accessible promoter pairs located within 50 Kbp and obtained positive correlation 
distributions indicating peak co-variation (Fig S3.3c). These values were further increased 
when considering only pairs with at least one DA-peak. When we considered only peak 
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pairs that are annotated as part of Hi-C contacts [Bonev et al 2017], a significant increase 
in the correlation values distributions was observed in links that are part of Neural 
Progenitors Cells (NPCs) and Cortical Neurons (CNs) versus Embryonic Stem Cells (ESCs) 
(Fig S3.3c). These cell type differences are the highest when either none or one of the peaks 
is a DA-peak, implying that DA-peak co-variability can be used to describe contacts that 
are not necessarily captured by Hi-C. Remarkably, IEGs related to neuron function are 
associated to significantly co-varying ATAC-seq peaks (Fig S3.3d).  
Collectively, these results reveal a complex landscape of chromatin accessibility changes 
during neuronal activity, and a coordinated interplay between chromatin accessibility and 
gene expression across stimuli, associated through co-variation between distal and 
proximal accessible regions. 
3.2.4. Subset of transcription factors underlies stimulus-specific accessibility 
responses  
To determine whether changes in chromatin accessibility after stimuli are related to 
transcription factors (TF), we searched TF motifs within the DA-peaks using 8-mers of 
108 TF specificity groups [Mariani et al 2017] and a database of Position Weight Matrices 
(PWMs) [Weirauch et al 2011] (both are henceforth referred to as “motifs”). For gained 
and closed DA-peaks in each treatment, we quantified the relative frequencies in 
comparison with a control set of negative sequences, and ranked TF motifs according to 
Receiver Operating Characteristic Area Under The Curve (ROC-AUC) values (Fig 3.3a; 
Appendix A). The basic region leucine zipper (bZIP) domain was the most enriched motif 
in DA-gained peaks for both BDNF and KCl (mean ROC-AUC = 0.65; P < 0.0001; Wilcoxon 
rank sum test) consistent with activity-dependent changes in bZIP expression playing a 
role in synaptic plasticity, learning and memory [Kandel et al 2012]. The positional 
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centrality of bZIP motif in DA-gained peaks suggests a role of these TFs as pioneers [Su et 
al 2017] (Fig S3.4a). 8-mers related to Homeobox (Hbox-III), and POU domain (POU; 
POU-HMG) were also enriched in DA-gained peaks for both treatments (ROC-AUC > 0.55). 
Two distinctive Homeobox subgroups, Hbox and Hbox-II, were only enriched in BDNF, 
suggesting a role for a subset of Homeodomain TFs in this chromatin response. 
Furthermore, gained DA-peaks in BDNF exhibited ETS, TALE-zfC2H2 and EGR motifs 
while in KCl we observed E2F-zfC2H2 and KLF motifs. The Early Growth Response (EGR) 
motifs, a class of IEGs is related to regulation downstream target genes involved in 
neurobiological processes such as synaptic plasticity and memory formation [Beckmann 
et al 1997, Gallitano-Mendel et al 2007]. Closed DA-peaks in BDNF contained HIC1 and 
RFX motifs, while in KCl included CCCTC-binding factor (CTCF), E2F, KLF, and zfCXXC-
SAND motifs (Fig 3.3b). 
As TFs of the same family can have similar DNA target sequences due to the shared 
recognition specificities [Mariani et al 2017], we examined whether individual TF 
expression levels can further define the observed motif enrichments. The bZIP group 
encompasses ten members and among them Fos, Fosb, Fosl2 and Atf3 showed significant 
up-regulated expression in both BDNF and KCl across time points (Fig. 3.3c). For BDNF 
increased expression of most bZIP members except Fos and Xbp1 disappeared at 6h, but for 
KCl expression of many bZIP members were maintained up to 10h. The EGR module 
contains eight members and four (Egr-1/2/3/4) of them are strongly induced by both BDNF 
and KCl. Importantly, up-regulated Egr-1/2 levels were only observed in BDNF but not in 
KCl which showed late reduction. On the other hand, HIC1 motif enrichment in closed DA-
peaks is consistent with higher expression levels of Hic1 in BDNF compared to KCl. As HIC1 
has been described to act as a repressor [Pinte et al 2004; Ubaid et al 2018, Boulay et al 
2012], this result suggests a link between HIC1 upregulation and stimulus-induced 
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chromatin accessibility decrease in BDNF. Unlike Hic1, CTCF did not show significant 
expression changes, yet its motif is highly enriched in 1h KCl closed DA-peaks, suggesting 
a specific layer of regulatory control linked to CTCF. Overall, we revealed coordinated 
binding and expression of TFs explaining the stimulus-specific changes in chromatin 
accessibility (mean fraction of DA-peaks explained by enriched TF motif = 68.8%) (Fig 
S3.4b). 
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Figure 3.3 Transcription factors linked to gained and closed DA-peaks reveal stimulus specific regulation. 
(a) Scheme indicating how gained and closed DA-peaks for a treatment-time combination are prepared for 
motif enrichment analyses (PWMs and 8-mers). (i) For each set of peaks, a background set of sequences 
matching genomic features is generated with GENRE. (ii) Each combination of foreground and background 
sequences is scanned in the motif databases, and ROC AUC values are generated for each combination. (b) 
Enrichment of main regulatory TF-modules enriched in gained and closed DA-peaks. Circle size indicates 
ROC AUC value and color indicates significance (Wilcoxon adjusted P-value). Bar plot compares highest value 
obtained between BDNF (green) versus KCl (orange). ROC AUC values lower 0.5 are depicted in gray. (c) Co-
enrichment of motifs in DA-peaks for 1h in KCl and BDNF. Network edges indicate fold enrichment (edge 
thickness) and Benjamini-Hochberg adjusted P-value (color). (d) Expression values for genes related to bZIP, 
CTCF, HIC1 and EGR k-mer groups. Significant log2 fold changes versus control are displayed with asterisks 
(using DESeq2 [Anders et al 2010]). 
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3.2.5. TF combinations define stimulus-specific gene expression 
Interaction between TFs can lead to more stable binding and function of the regulatory 
element [Vandel et al 2019, Jolma et al 2015; Junion et al 2012]. We therefore examined 
pairs of TF motifs in 1h BDNF and KCl carrying most DA-peaks to assess their collaborative 
role in chromatin accessibility changes. By significance, the strongest combination of 
three motifs DA-peaks for both treatments was for between EGR, HIC1 and CTCF (FE = 2.3 
and 2.8 for BDNF and KCl respectively, adjusted P < 0.0001). Additionally, the combination 
of these factors with bZIP is also enriched, suggesting a coordination between bZIP 
pioneering activity and the interactions observed for these three factors (FE = 2.2 and 1.7 
for BDNF and KCl respectively; adjusted P < 0.01). Co-occurrence of TF motifs can define 
cell-type specific enhancers and be used to understand their response [van Bömmel et al 
2018]. Indeed, co-occurrence of EGR and bZIP motifs significantly increases chromatin 
accessibility compared to either bZIP or EGR alone in BDNF gained DA-peaks (Fig. S3.5c), 
suggesting an interaction between pioneer factor and co-regulator. Furthermore, co-
occurrence of bZIP and EGR motifs in gained DA-peaks associated with Transcription Start 
Sites (TSSs) (<5kb) lead to a significant upregulation of genes for 1h BDNF, but not for KCl, 
compared with either bZIP or EGR alone (Fig. 3.4b). Thus specific increase in chromatin 
accessibility consisting of the two TFs (e.g., bZIP and EGR) upon BDNF treatment 
contributes to gene expression synergy.  
Among the genes showing high correlation between accessibility in putative DREs and 
expression (Fig 3.2g) we found the Activity Regulated Cytoskeleton associated protein 
(Arc), which is a well-known IEG pivotal for learning and memory formation [Tzingounis 
et al 2006, Plath et al 2006]. Arc is induced by both BDNF and KCl but higher at 1h BDNF 
(Fig. 3.4c) consistent with a coinciding increased accessibility at both the promoter and 
putative DRE region. We considered this region an enhancer for Arc because of its 
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enhancer-related histone modifications present in neuronal epigenomes data (H3K27ac 
and H3K4me1) [Malek et al 2014]. Additionally, CTCF tracks [Sams et al 2016; Ren et al 
2017], and a Hi-C contact between Arc gene and this DRE region are observed [Bonev et al 
2017]. 
The Arc gene enhancer region contains the DA-peak specific to BDNF which carries four 
important TF motifs (bZIP, EGR, HIC1 and Hbox-II) (Fig 3.4c). As co-occurrence of bZIP 
and EGR motifs in DRE showed higher expression of the linked gene, we hypothesized that 
the accessibility increases at DRE could explain a higher Arc expression in BDNF compared 
to KCl. Also, HIC1 is present in the DRE. Like other IEGs, expression of Arc goes down after 
1h, therefore, HIC1 might contribute as a repressor in this downregulation by binding to 
the Arc enhancer region in a BDNF-specific manner.  
To validate the role of the Arc gene DRE in BDNF-mediated gene expression, we tested 
variants that remove sections of the Arc enhancer containing EGR and HIC1 motifs by 
means of CRISPR-Cas9. Indeed, significant reduction of BDNF-mediated Arc gene 
expression occurred in DRE deleted clones, but not in control (Fig. 3.4d) indicating that 
this DRE is involved in BDNF-specific Arc up-regulation. Altogether, our results show a 
complex interaction between TF combinations and DREs to control the expression of 
neuronal activity related genes in a stimulus-specific way. 
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Figure 3.4 Variability in BDNF gene expression is linked to bZIP+EGR combinations acting in promoters and 
enhancers. 
(a) Accessibility changes for BDNF and KCl peaks grouped by presence of k-mers for bZIP (green), EGR (blue), 
or their combination (bZIP+EGR, red). Lines in density plots indicate median value for distributions. (b) 
Expression of genes with TSS proximal to DA-peaks, subset by k-mers for bZIP (orange), EGR (green), or 
both (red). Asterisks indicate adjusted p-values derived from Wilcoxon test. (c) Chromatin tracks of Arc gene. 
Blue = 1h ATAC (counts per million); Green = 1h RNA-seq (counts per million); Brown = H3K27ac; Purple = 
H3K4me1 [Malek et al 2014]; Pink = CTCF [Sams et al 2016; Ren et al 2017]; Gray = Cortical neurons Hi-C data 
[Bonev et al 2017]. Red bars in ATAC-seq tracks indicate gained DA-peaks in BDNF, and red bars in RNA-seq 
tracks indicate differential expression in BDNF and KCl. The green block in Hi-C tracks represents the anchor 
point for calculation of scores, using Shaman. The curved line between ATAC-seq peaks indicates the 
Spearman correlation of the normalized counts. Motif names indicate presence of k-mers for enriched 
specificity groups in those peaks. (d) Arc expression in BDNF is reduced upon deletion of selected regions in 
enhancer (* = P < 0.05 using two-sided t-test). 
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3.2.6. CTCF at promoter-exon loops is linked to differential exon usage in 
neuronal genes.  
CTCF enrichment in KCl closed DA-peaks suggests a regulatory role of this TF in neuronal-
activity. CTCF controls genome organization by forming TADs [Hansen et al 2018], and 
intra-TAD contacts can direct enhancers to its target promoters by CTCF looping 
[Heintzmann et al 2007]. CTCF has also been associated through genetic variation [Li et al 
2016] and promoter-exon contacts [Ruiz-Velasco et al 2016] to splicing. As CTCF motifs 
are enriched in closed DA-peaks in 1h KCl (Fig. 3.3b), we sought to study further 
associations between CTCF and gene regulation (Appendix A). Interestingly, we found and 
enrichment of 1h KCl DA-closed peaks for CTCF promoter-exon loops (odds ratio= 3.5; 
adjusted P < 0.001; Fig. 3.5a), an enrichment of convergent CTCF motifs for those peaks, 
and a stronger enrichment in KCl than in BDNF for DA-peaks with CTCF binding sites in 
both intronic and exonic regions (Fig S3.6a-b). This result suggests that CTCF might 
regulate transcriptional events after transcription initiation in a treatment specific way 
[Stadhouders et al 2012] by hindering Pol II elongation and alternative mRNA splicing 
[Paredes et al 2013; Shukla et al 2012; Ruiz-Velasco et al 2017]. Thus, we assessed the 
levels of differential usage of exons (DUEs) between BDNF and KCl. Globally we found 7188 
exons differentially used within their genes between BDNF versus KCl (FDR = 10%). When 
filtering for DUEs with at least ≥2 fold change; the expression levels of 307 exons were 
repressed and 1246 exons showed increase in expression between BDNF and KCl (Fig 3.5b). 
To validate this, we selected three genes with important roles in neuronal function and 
activity, containing a significant differentially used exon and a CTCF loop between the DUE 
and promoter: Trio Rho Guanine Nucleotide Exchange Factor (Trio) [Fujita et al 1998], 
Syntaxin Binding Protein 5 (Stxbp-5) and Carboxypeptidase E (Cpe-201) [Woronowicz et al 
2010]. We used RT-qPCR assay to quantify relative exon usage - one exon was 
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differentially used based on our analysis and the other exon was from the same gene but 
remained unchanged between treatments, and was used for within-gene correction. We 
normalized the expression changes with Rpl13 as a reference gene and compared the exon 
ratio (fold change ratio between positive and control exon) for BDNF, KCl and untreated 
neurons.  
Haploinsufficiency in Trio causes severe deficits in behavior and neuronal structure and 
function [Goebbels et al 2006; Katrancha et al 2019]. Expression of Trio DUE exon 29 
located in the last exon of a transcript variant that carries an additional 3’UTR sequence 
showed a significantly higher exon ratio relative to the regular exon 29 (without 3’UTR) in 
BDNF versus KCl at 1 h (mean exon ratio = 1.4 and 0.9 for BDNF and KCl respectively; 
adjusted P < 0.001, two-sided t-test). Stxbp5 functions to regulate synaptic capturing and 
recycling of secretory vesicles with the presynaptic plasma membrane [Geerts et al 2017]. 
Murine Stxbp5 has at least 15 transcript variants and we revealed that DUE exon 1 compared 
to exon 5 showed a higher expression in BDNF than KCl at 1 h (mean ratio = 1.15 versus 1.1; 
adjusted P < 0.01, two-sided t-test). Cpe-201 acts as neurotrophic factor to promote 
neuronal survival [Cheng et al 2014] and can also function as a sorting receptor that can 
bind to BDNF [Lou et al 2005]. DUE number 9 of Cpe-201 versus exon 6 showed a higher 
exon ratio increase at 1h for neurons treated with BDNF in comparison to KCl (mean ratio = 
1.13 versus 1.03; adjusted P < 0.01, two-sided t-test). Taken together, our results 
demonstrate a stimulus-specific regulatory layer associated to alternative transcription in 
neuronal activity, likely mediated by CTCF. 
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Figure 3.5. (legend on next page) 
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Figure 3.5 Association between CTCF in DA-peaks and differential exon usage. 
(a) (left) Depiction of promoter-exon CTCF loops. CTCF peaks (pink) pairs contain one peak close to the gene 
promoter region, and another peak close to exons. These peaks contain CTCF motifs that can be in convergent 
orientation (green arrows).  (top heatmap) Odd ratios for enrichment of promoter-exon CTCF loops in gained 
and closed DA-peaks. Promoter-exon loops are defined in [Ruiz-Velasco et al 2017]. (bottom heatmap) 
enrichment of convergent CTCF motifs in promoter-exon regions overlapping gained or closed ATAC-seq 
peaks (b) Exon log2 fold changes between BDNF and KCl in 1h as quantified by DEXSeq [Anders et al 2012]. 
Orange dots indicate Differentially used exons (DUEs), and red dots indicate DUEs with promoter-exon CTCF 
loops in their genes. Genes highlighted in blue are selection for validation. (c) (top) Genome tracks for Trio, 
Stxbp5 and Cpe genes. (middle) Depiction of reference DUE exon (ref) and control exon (gray) used for 
comparison using RT-qPCR. (bottom) Fold change ratios between reference and control exons at 1h after 
treatment with BDNF (orange), KCl (green), and control (gray). Asterisk indicates significant change versus 
control (two sided t-test). Bottom plot shows log2 fold changes for gene expression values versus control (*= 
P < 0.1 in treatment versus control comparison of normalized counts using DESeq2 (Appendix A)). 
3.3. Discussion 
In this work we have performed a comprehensive temporal analysis of gene expression 
and chromatin accessibility changes to compare neuronal activity dynamics across 
multiple stimuli. The integration and dissection of involved regulatory elements allowed 
us to predict and validate principles that determine specificity among these stimuli and are 
especially relevant for neuron function. We identified functional expression profiles 
explaining early and late waves of gene expression separating KCl, BDNF and Forskolin 
responses. Despite the global agreement between early expression profiles, our results 
suggest a differential outcome in expression programs, likely mediated by specific TFs 
modulating the common early response into targeted functional outcomes. Further work 
would be required to identify TFs or additional factors affecting the expression of these 
induced early genes. 
The integration of our time-course chromatin accessibility data with other epigenomes 
and HiC-contacts data allowed us to pinpoint features that distinguish BDNF and KCl 
responses. Importantly, we found a strong coordination between distal regulatory 
elements and target genes as an early event in BDNF-induced neuronal activity, whereas 
for KCl the early expression response was mainly defined at the level of promoter regions, 
indicating that early neuronal expression events are associated to active TSS elements. 
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Additionally, the independent clustering of accessibility and expression data (Fig 3.1a, 
3.2a) and the observation of late coordination for accessibility and expression for both 
treatments (Fig 3.2f) suggest major rearrangements in the chromatin landscape affecting 
enhancers at late time points. 
Through an extensive analysis of TF motif signatures at differentially changing accessible 
regions we predicted TFs involved in regulating the chromatin landscape, and 
combinatorically controlling gene expression. The AP-1 complex acts a classical pioneer 
factor (bZIP module in our work) [Biddie SC et al 2011] and explains a major part of the 
gained chromatin regions across tested stimuli. Importantly, we identified multiple 
secondary TFs enriched along bZIP motifs such as Hbox/EGR/HIC1 and CTCF, and in the 
case of HIC1 and EGR found them to be specifically associated to the BDNF response 
through their expression levels, which is also in agreement with the prediction of bZIP-
related TFs such as cFos recruiting co-regulators that ultimately determine response 
specificity [Su et al 2017]. EGR motifs predominantly act as co-regulators and specifically 
increase gene expression of target genes upon BDNF treatment. HIC1 motifs, on the other 
hand, are usually associated with co-repressing specific subsets of binding regions opened 
by BDNF, and overall closing of early accessible regions. The co-enrichment of HIC1 and 
EGR motifs hinted at a further regulatory role through interaction of these factors, where 
HIC1 presumably acted as an early repressor of regions activated by bZIP and EGR. We 
mapped a distal regulatory element active in BDNF and identified the differentially 
increasing Arc gene expression to be controlled by a combination of these factors (bZIP-
EGR-HIC1). The reduced expression of Arc, concomitant to disruption of enhancer EGR 
and HIC1 motifs in the associated distal regulatory element highlights a precise activation 
of gene expression which is likely mediated by interactions between bZIP and EGR/HIC1. 
The role of these factors thus constitutes a functional triad that modulates the response 
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specificity in BDNF, and its additional functional roles and interactions with the repressor 
TF HIC1 remain to be understood.  
The enrichment of CTCF motifs on early closed KCl peaks and the recently reported CTCF 
role in alternative splicing to KCl response in closed peaks [Ruiz-Velasco et al 2017], 
suggests an association between CTCF and differential exon usage. We validated our 
hypothesis using three genes shown to be affected and involved in neuron function. These 
results highlight a formerly unexplored response mechanism in classical neuronal activity. 
Behavioral processes, including learning, have been related to genes and variants affecting 
the Trio gene in regions close to our reported DUE [Pengelly et al 2016]. Chromatin 
accessibility and promoter-exon loop contacts could therefore potentially mediate 
responses through treatment-specific exon usage. Finally, as Trio contains several Single 
Nucleotide Polymorphism associated to learning in targeted domains of this protein close 
to our studied exon [Pengelly et al 2016; Sadybekov et al 2017], the alternative splicing of 
these genes could potentially mediate functional outcomes. Further work requires finding 
how these CTCF associated chromatin changes are triggered and understanding their 
specific functional consequences. 
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Chapter 5 
 
Conclusions & Outlook 
 
The rapid advent of sequencing technologies has allowed us in recent years to 
comprehensively describe the biological consequences of transcription factor (TF) 
binding at multiple levels. Various experimental techniques, their customized versions, 
and multi-omics data integration enable the tracking of changes in the regulatory 
genome concomitant to binding of TFs. Thus, it became possible to directly probe causal 
gene-regulatory networks and to connect them with downstream biological functions. 
This thesis has carefully explored the regulation of gene expression in this context and 
provided answers to the following questions: 
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Question 1: Can we predict TF-cooperativity and features allowing its prediction 
in published TF-binding data? 
The work presented in Chapter 2 describes the integration of publicly available SELEX 
data capturing TF-DNA binding in pairs and alone. The presented statistical framework 
for the assessment of features contributing to binding predictions allowed us to observe 
improvements for certain TF family combinations that had not been reported before, 
such as the one for Forkhead and Ets families. Our findings highlight the potential of 
describing these interactions across multiple TF pairs and their functional consequences 
more thoroughly. Importantly, the selection and experimental validation of specific cases 
of DNA sequences- classified as cooperative or non-cooperative for the FOXO1-ETS1 
pairs- substantiated the potential of our computational approach to predict cooperativity. 
Question 2: What are the consequences of cooperative TF-binding in function 
and disease?  
The second part of the work described in Chapter 2 integrates multiple ChIP-seq datasets 
and prior knowledge of protein-DNA interactions, allowing the interrogation of 
functional terms related to single TFs and their joint presence. Benchmarking across 
different databases indicates that these associations increase discovery of ontologies 
specifically related to TF-TF binding events where both members are part of the 
ontology. This proves more accurate than approaches where only co-occupied regions are 
considered without TF-TF binding information. We therefore conclude that knowledge of 
TF-TF binding combinations independently contributes to biological processes related to 
function and disease. 
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Question 3: What is the interplay between TFs and chromatin accessibility and 
how does it confer specific neuronal activity? 
In Chapter 3 the combined assessment of neuronal accessibility changes and gene 
expression in mouse cortical neurons for different treatments revealed common and 
specific features, with strong response-specific TF associations. Functional validation of 
specific cases through analysis of expression data allowed the dissection of specific 
response types and their consequences. Specifically, interactions between TFs from the 
groups bZIP, EGR, CTCF, HIC1 and Hox genes are related to chromatin accessibility and 
gene expression upon BDNF or KCl stimulations, with a predicted weaker role for HIC1 
and EGR in KCl. Strikingly, we also observed differences in exon usage between these 
treatments that are potentially due to the interaction between CTCF promoter exon-
loops, most likely triggered by EGR-related factors and HIC1. These results demonstrate 
that a well-established interplay of TF combinations have a direct functional impact on 
the onset of neuronal activity. 
Question 4: Embargoed until 15 Sep 2021
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5.1. Relevance of TF cooperativity in the understanding of Biology. 
In order to understand the biological consequences of a molecular readout, i.e. interpret 
the readout per se, we take the most explanatory variables in our models and try to predict 
the system output by perturbing those [Lazebnik 2002]. In the context of TF regulation in 
vivo, their contribution in maintaining a cell state seems to be hierarchical, as few TF 
motifs are able to explain the major changes in genomics data. This regulatory setup is in 
agreement with the observation of multiple TFs being expressed in multiple tissues, with 
just a few ones being differentially expressed or not at all in particular cell types [Wei et al 
2018]. Systematically adding TF-TF interactions into these predictive models as a 
component allows then to assess the contribution of combinatorial TF-binding to 
biological processes in general. However, quantifying and assessing the improvement in 
these types of models is beyond the scope of this dissertation. Further adaptations of the 
work presented in Chapter 2, with incorporation of additional data, could be promising to 
discover TFs related to function or disease, through interactions with another TF and TF-
TF cooperativity. 
The discussion on whether such alternative binding models or TF-TF combinations are 
relevant, arguably ensues a quantitative statement on the additional variance explained 
with respect to the additional number of features that would be included. In Chapter 2 and 
Chapter 3 we deliberated on the possibility of clustering specific genome regions in an 
unsupervised way to systematically interrogate the contribution of TF-TF binding to TF-
regulatory models. Our results indicate that such TF-cooperative binding events are 
involved in function and disease. However, the number of such TF-TF binding events is 
considerably lower than the number of events that involves primary TF-binding. 
Ultimately, cooperative TF-TF interactions together with single TF binding contribute to 
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the eventual biological output, and it is the quantitative estimation of the contribution for 
each TF-TF interaction, on top of single TF binding, that would require further work. 
As explained in the Introduction, interactions that are not mediated by direct TF-TF 
binding (DNA-mediated or DNA-cooperative interactions), can also translate into 
cooperative interactions, i.e. when TFs bind to proximal or same regulatory loci of 
identical or complementary genes. In the case of neuronal activity, TFs with the pioneer 
bZIP domain and TFs of the groups Homeobox/EGR/HIC1 and CTCF functionally 
cooperate to bind similar regions upon stimulation. These interactions modes mediate 
very specific downstream responses in cortical neurons that cannot be observed for all 
neuronal activity stimuli. It is the target of further research to determine which and why 
EGR-related factors and HIC1 partners are acting specifically upon BDNF treatment and 
not upon KCl stimulation (Chapter 3). 
Given that cell differentiation and fate maintenance heavily rely on a tight control by TFs, 
it is an open question whether TF combinations affect differentiation and to what extent 
those combinations can be identified (Chapter 4). From our results in Chapter 2 we can 
conclude that specific TF pairs are linked to genes regulating neuron differentiation and 
keratinization (Fig S2.7). This sheds light on DNA-facilitated TF-binding determining the 
activation and repression of target pathways related to cell fate in a TF-TF specific 
manner. Ultimately, leveraging such additional knowledge on TF-TF binding and their 
functional consequences in prediction models could allow a rational prioritization of TFs 
for cell reprogramming. 
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5.2. Integration of TF binding data with other -omics datasets 
The vast amounts of TF binding data, along with the remarkable improvements in the 
computational methods for analysis and integration will undoubtedly spur an upcoming 
progress in the active interpretation of the genome and its regulation. Combined models 
that take into account genomic data across studies is a priority in bioinformatics 
methods. Preliminary solutions such as the UniBind database [Gheorghe et al 2019] allow 
for a comparison of TF binding models, but lack a systematic integration with other 
omics layers. New tools such as Virtual ChIP-seq [Karimzadeh et al 2019], for example, 
attempt to predict TF binding from expression and ATAC-seq data, but have implemented 
their TF binding priors based on PWMs scores only (see Introduction 1.2). Considering all 
the caveats of PWM-based models discussed previously by others [Ruan et al 2017] and in 
this work, models for such resources need to be adjusted accordingly. It will take a 
community effort and large-scale coordination for methodologies to shift from mere 
PWMs to inclusion of k-mers [Guo et al 2018], biophysical models [Rastogi et al 2019], 
and TF-TF cooperativity. Such a change in the methodological paradigm in the TF-
modeling promises to have a big impact in the upcoming years, allowing the description 
of wider binding affinity spectrum for protein-DNA interactions. 
Moreover, the rules guiding cooperativity, as presented in this work, do not just apply to 
TF-DNA interactions, but to nucleic acids in general, including interactions between 
proteins and RNA. It is widely assumed that RNA-recognition properties of proteins are 
comparable to sequence-specific TFs [Jolma et al 2019], but with higher degrees of 
freedom of the RNA-molecule during the formation of tertiary structures. This work 
hence gives some directions on potential assessment of RNA-binding protein 
cooperativity from available data [Ray et al 2017], and their association to biological 
processes. 
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Consortia efforts have associated human genetic variation to molecular phenotypes at the 
level of Single Nucleotide Polymorphisms (SNPs). A fraction of those SNPs has been 
associated to TF binding, either at the level of allele-specific binding or at the level of 
chromatin marks affected by such [Shi et al 2016]. As 15-20% of all SNPs seem to be 
associated to a TF binding model [Grubert et al 2015; 1000 Genomes Project 
Consortium], an unanswered question is to what extent TF-TF interactions cooperativity 
binding can increase the unexplained fraction, and ultimately bridge the gap between 
genetic variation and phenotypes. As GWAS variants are linked to biologically relevant 
phenotypes through TF-cooperative binding [Iwata et al 2017], it is expected that more 
variants associated to low-affinity TF-binding sites and TF-TF interactions will be 
discovered in the next years. Approaches such as the one developed in Chapter 2 will be 
helpful to readily mine public genetic data for this purpose. 
Expression data has been proven useful to assess TF combinations and their enrichment 
in ChIP-seq data as co-regulators [Mariani et al 2017]. As TF-cooperative binding events 
are promiscuous but limited to certain TFs families, the results described in all chapters 
indicate novel ways of reducing the search space by using TF expression levels, and 
monitoring cooperativity events between TFs in context of certain molecular phenotypes. 
The future incorporation of known or predicted TF-interactions, their expression and any 
additional data will be useful for the assessment of how specific TF-pairs are linked to 
function or disease. 
The findings and discussions presented in this dissertation should ultimately shed light 
on TF cooperativity as an important contributor to the precise regulation of a biological 
system. With TFs being prime determinants of cellular programs, the further study of the 
molecular interplay between TFs and their functional consequences is crucial to the 
overall understanding of biology.  
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Appendix A 
 
Computational Materials and Methods 
 
Related to Chapter 2 
Transcription factor binding datasets 
Transcription factor (TF) binding data analyzed in this work was collected from in vitro 
and in vivo studies. Specifically, CAP-SELEX and HT-SELEX sequencing reads are 
retrieved from the European Nucleotide Archive, under accession entries PRJEB7934, 
PRJEB7934, and PRJEB20112, respectively. Protein Binding Microarray (PBM) data was 
downloaded from the UniProbe database [Newburger et al 2013]. ChIP-seq peak datasets 
are collected from the ReMap2 database [Chèneby et al. 2018]. 
In vitro data preparation 
The first step in the computational processing of SELEX data is the generation of count 
tables for k-mers (sequence patterns of length k), for each experiment where a TF or a TF 
pair was processed. CAP-SELEX sequencing data used to generate count tables always 
comes from a fixed selection round (positive) and is compared against an input library 
(background, or round zero). For each TF pair we select the positive round where a 
binding motif targeted by the two TFs is overrepresented in the reads for a given topology 
versus all other possible topologies [Jolma et al. 2015]. From this, the initial value of k is 
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the length of the reported reference k-mers, trimming out ambiguous nucleotides in the 
flanking (N). For example, the reference k-mer GAAAACCGAANM has a length of 12, and 
thus k = 12. If more than one reference k-mer is enriched in one dataset, those are 
processed independently.  
Once k-mer tables are defined, relative affinity estimates for each k-mer can be obtained 
from the counts of each k-mer observed in the positive round, versus the amount 
estimated in the input data (round zero) using a fifth-order Markov Model. This 
correction takes into account sequencing biases [Riley et al. 2014]. Given this 
information, for a k-mer 𝑘 in selection round 𝑟, its relative affinity or 𝑆(𝑘, 𝑟) is calculated 
as 
𝑆(𝑘, 𝑟)  =  1+𝑟�𝑃𝑜𝑏𝑠(𝑘, 𝑟)/𝑃𝑒𝑥𝑝(𝑘, 𝑟 ) 
 
Where 𝑃𝑜𝑏𝑠(𝑘, 𝑟) is the fraction of counts for 𝑘 in 𝑟, and 𝑃𝑒𝑥𝑝(𝑘, 𝑟) is the expected fraction of 
counts for 𝑘 in round 𝑟. The derivation of the formula has been extensively described in 
previous work [Riley et al 2014].  
From the k-mer tables and their relative affinity estimates, we further subset this table 
for k-mers with high similarity between those and the reference k-mers indicated to be 
enriched, allowing up m mismatches [Yang et al. 2017]. The m value threshold is 
proportional to the consensus sequence length and the information content of each of its 
nucleotides, using the proposed formula 
𝑚 = ⌊(𝐿 −  4)/2⌋  +  1  
where 𝐿 is the length of the consensus sequence, corrected by the ambiguity of each 
nucleotide. E.g. GAGCA has an 𝐿 value of 5, but RRGCA has an 𝐿 value of 4, as R can 
represent either G or A.  
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Tiled k-mer tables 
There is an exponential decrease in the counts recovered per k-mer and the value of k, 
which prevents the calculation of robust k-mer tables and robust relative affinity 
estimates for high k values. To overcome this, we trimmed nucleotides from both flanking 
regions of each consensus sequence in the list derived from the CAP-SELEX data. We 
thereby obtain tiled k-mer tables with sufficient counts for further analyses. To avoid 
lower complexity of DNA sequences, tiled k-mer tables of length lower than 10 are not 
considered for further analyses. Our trimming approach was benchmarked through a 
comparison of the effect of shorter k-mers in the final performance metrics (see section 
“Trim-and-summarize coefficient of determination” and Fig S1a-b and S4). To avoid 
relative affinity estimates with low support, minimum threshold of counts per k-mer are 
defined [Riley et al 2014; Yang et al 2017]. In this work, k-mers derived from CAP-SELEX 
data are discarded if the number of counts is lower than 20 counts. 
Regression models and features describing SELEX relative affinities  
To relate binding affinities with sequence and/or shape features we used L2-regularized 
Multiple Linear Regression (L2-MLR), in the form: 
𝑦 = 𝛽0 + 𝛽1𝑋1 + 𝛽2𝑋2+. . . +𝛽𝑛𝑋𝑛 
 
where 𝑦 is the vector of relative affinities for each k-mer in the k-mer table, whereas 𝑋 
represents a concatenated set of features that encode their respective DNA sequences, 𝛽𝑖 
(i=1,…,n) represent the regression coefficients, and 𝛽0represents the intercept. To prevent 
overfitting, L2-regularization employs an additional penalty term on the coefficients in 
the loss function 𝐿(𝛽), i.e. coefficients are obtained by minimizing 
𝐿(𝛽)  = �(𝑦𝑖 −  �𝛽𝑗𝑋𝑖𝑗
𝑝
𝑗=1
)2
𝑛
𝑖=1
+ 𝜆�𝛽2𝑗
𝑝
𝑗=1
 
with 𝜆 set to one. 
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For regression models based on DNA sequence features, the baseline models are named 
1mer and are defined by mononucleotide representations of each k-mer. At any k-mer 
position 𝑖, four features 4𝑖 to 4𝑖 + 𝑗 with 𝑗 < 4 are defined based on the nucleotide identity 
of 𝑘𝑖: 
𝑤𝑖𝑡ℎ 𝑁0 = 𝐴,𝑁1 = 𝐶,𝑁2 = 𝐺,𝑁3 = 𝑇 
 
In total, 1mer models require 4𝑘 features for each sequence of length k to fully encode its 
sequence in numbers. For 2mer or 3mer models, dinucleotide or trinucleotides are also 
converted into coefficients, thus requiring more features per position. For 2mer models 
features, 16 coefficients between 16𝑖 to 16𝑖 + 𝑗 with 𝑗 < 15 features are necessary to 
describe the dinucleotide identity of each k-mer position and its immediate right-
nucleotide 
 
𝑤𝑖𝑡ℎ 𝑁0 = 𝐴𝐴,𝑁1 = 𝐴𝐶,𝑁2 = 𝐴𝐶,𝑁3 = 𝐴𝐺, . . . ,𝑁15 = 𝑇𝑇 
 
Similarly, for 3mer models 64 features representing all the possibilities for trinucleotides 
are required. In general, for a Nmer model where 𝑁 ∈  𝑍+, 4N would be required per k-mer 
position. Combinations of these models require the sum of features for each individual 
model, per position. For example, 1mer+2mer models require 41 +42 = 20 coefficients per 
position. Equivalences between some of these models are further described in [Yang et al 
2017].  
Models that include DNA-shape features are labeled with the keyword shape (e.g. 
1mer+shape), and consider DNA structure estimated for each tested DNA-sequence in all 
datasets, defined as descriptors of the overall DNA structure for that sequence. These 
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values are listed in a DNA pentamers table, and are obtained from the DNAShapeR 
package [Chiu et al 2016] centering each feature value on the middle nucleotide. In this 
work, we considered the four main features provided in the original version of this table: 
Propeller twist (ProT), Roll, Helical Twist (HelT), and Minor Groove Width (MGW). In 
addition to these values, second order shape values are obtained by calculating the 
product of features in two consecutive positions, as a way to describe longer structure 
features. For that reason, 4 main shape and 4 second order shape features are required 
per position, allowing for 8 features per position to be described in shape models. 
Additively, 1mer+shape models require 4 + 8 = 12 features per position where a centered 
DNA pentamers exists. 
Flanking positions cannot be described by shape features as these miss one or two 
nucleotides to successfully map a DNA pentamers. Solutions such as describing the flanks 
as 3mer features have been proposed (1mer+3merE2, where E2 symbolizes using 3mer 
features in the two end positions) [Yang et al 2017]. In this work, we extended the shape 
model features to include flanking regions as well by including the average feature value 
of all pentamers that contain a common tetramer or trimer as found in the flanking 
region. Briefly, whenever a shape feature in the flanking regions is required, we average 
pentamers shape features that contain a fixed trimer (16 options) or tetramer (4 options). 
This is done with similar rules and upstream or downstream of the k-mer flank, 
according to the 5’ to 3’ directionality (left flank = upstream trimming, right flank = 
downstream trimming), respectively. We calculated errors for each DNA-pentamers to 
estimate the amount of uncertainty for each calculation using all trimers and tetramers 
available in the dataset in comparison with all DNA-pentamers. Shape features based on 
averaging across trimers and tetramers are closer to real pentamers DNA-shape features 
than the global mean generated by using all 1024 DNA pentamers or scrambled versions 
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of it. In this work, we refer to shape features as models that include these flanking 
features. 
Trim-and-summarize coefficient of determination 
For each tiled k-mer table in each dataset, we use a 10-fold cross validation scheme to 
randomly separate the table into 10 fixed groups of equal size, iteratively fitting L2-MLR 
models with 9 out of ten groups, and then assessing coefficient of determination (R²) in 
the held-out group. This is done using scikit-learn [Pedregosa et al. 2011]. As a summary 
statistic for each tiled k-mer table, we report the median R² of all held-out groups. As a 
quality control and to remove datasets with low variability and enrichment for mapped k-
mers, at this stage we filter out datasets whose minimum testing R² value across all 
models for all tiled k-mer tables is lower than zero (i.e. fitting is worse than using the 
mean of all values as a single feature). 
To generate a global R² for each dataset and model combination, we calculate the median 
of all median 10-fold CV R² values in each tiled k-mer table when using a reference k-
mer. We refer to this as the ‘trim-and-summarize’ R² performance, and use this number 
for global performance comparison across models and datasets (Fig S2.1a). To validate 
that this metric is a robust approach to obtain global R² values without major information 
loss, we tested whether this approach provides similar R² statistics to the ones reported 
by Yang et al in HT-SELEX data [Yang et al 2017], comparing reference k-mers and tiled 
k-mers. Globally, R² statistics are in strong agreement, defined as a difference of less 
than 3 nucleotides between models for reference and tiled k-mers. Hence we conclude 
that R² values obtained through trim-and-summarize are indicative of longer k-mer R² 
values as long as the length difference with respect to used tiled k-mers is three or less 
(Fig S2b). 
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TF family shape-specific improvements in combinatorial binding 
We assessed the relationship between our trim-and-summarize R² improvements by 
DNA-shape features and specific TF family membership of each studied pair of TFs. 
Briefly, each annotation for a TF to a particular protein structure family is retrieved by the 
JASPAR database [Mathelier et al. 2014]. Significant increases in R² are assessed using a 
Wilcoxon rank sum test (wilcox.test in R), with p-values being corrected using a 
Benjamini Hochberg procedure (p.adjust in R) [Benjamini et al. 1995]. 
To discard bispecificity in the Forkhead+Ets datasets as a feature explaining the R² 
improvements, we repeated the calculation for these datasets discarding all k-mers 
containing the pattern GACGC up to one mismatch (Fig S1d). 
Cooperativity estimations in matched CAP-SELEX and HT-SELEX data 
To estimate TF cooperativity we used relative affinities obtained from CAP-SELEX and 
HT-SELEX data, and their predicted scores from 1mer+shape models. We defined the ratio 
between predicted relative affinities for a TF pair and matched single TF datasets, to 
estimate how close a CAP-SELEX score is to the average score in matched HT-SELEX data 
that would be expected for non-cooperative binding. Hence, the cooperativity for a k-mer 
𝑘 is defined as  
𝑐𝑜𝑜𝑝𝑒𝑟𝑎𝑡𝑖𝑣𝑖𝑡𝑦 = 𝑆𝑎𝑏(𝑘) / 𝑚𝑒𝑎𝑛(𝑆𝑎(𝑘𝑎),𝑆𝑏(𝑘𝑏)) 
 
where 𝑆𝑎𝑏(𝑘) is the predicted relative affinity in CAP-SELEX for TFs a and b, and 𝑆𝑎(𝑘𝑎) and 
𝑆𝑏(𝑘𝑏) are the predicted relative affinity estimates obtained for TFs a and b in HT-SELEX 
data for subsequences 𝑘𝑎 and 𝑘b that are contained in 𝑘. Lengths for 𝑘𝑎 and 𝑘𝑏 are selected 
based on [Yang et al 2017]. This score can be used to calculate the relative cooperativity 
for specific DNA sequences within a TF pair given the three experiments that are 
available. In this study we limited calculations to DNA sequences that contain motifs 
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associated to at least one TF, to prevent calculation of cooperativity estimates on DNA 
sequences that are linked to amplification and sequencing biases rather than TF binding 
specificity. 
Since no HT-SELEX data was available for ETS1 we used the FOXO1:ELK3 CAP-SELEX 
dataset to estimate cooperativity factors for the TF pair FOXO1:ETS1, as it contains one 
common member, FOXO1, and ELK3 is a paralog to ETS1. To generate k-mer tables, we 
used k=13 for FOXO1:ELK3 (reference k-mer: RTMAACAGGAAGT), k=12 for ETS1 
(NNNNGGAANNNN), and k=8 for FOXO1 (RTAAACAW). This setup allows to measure 
cooperativity estimates using 1mer+shape models that contain the Forkhead-Ets 13-mer 
binding pattern, plus two 3’ flanking positions to align the ETS1 binding model 
(minimum k = 15). 
PBM data analysis 
To examine the DNA binding affinity of Forkhead TFs for ω-none, ω and ω-high, we used 
PBM data from the UniProbe database to compare E-scores for all 8-mers containing the 
patterns GTAAACA, AACAACA, and ACGCACC across all available Forkhead family 
members. The E-score threshold of 0.35 is used to define high-affinity sites.  
Shape profiles calculation 
To quantify the contribution of DNA-shape in each TF binding position, we adapted an 
approach based on a conservative estimation of the performance change in R2 after adding 
or removing a given shape feature in a given position [Yang et al 2017]. Briefly, for each 
position i in the TF binding model based on a consensus k-mer of length k, we calculated 
the minimum absolute change in the R2 value (ΔR2) between two schemes: (i) increase after 
adding shape features in a sequence-only model (1mer+shapei) and (ii) decrease after 
removing a shape feature in a shape-only model (shape-shapei) 
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(i) a = max(ΔR2(1mer,1mer +shapei), 0) 
(ii) b = max(-ΔR2(shapei, shapei -shapei), 0) 
From these two values, then the ΔR2 per position (ΔR2p) is defined as  
(iii) ΔR2p = min(a, b)  
We considered tiled k-mers for the calculation of this value in CAP-SELEX data, so as the 
improvements are summarized by the median across all aligned positions in tiled k-mers. 
Similar to the trim-and-summarize R2 comparisons in HT-SELEX data, we tested whether this 
scheme produces reliable agreements between ΔR2p profiles obtained between reference k-mers 
and their shorter tiled k-mers. For a number of trimmed positions equal to three, we have 
obtained a positive correlation distribution between k-mers and trim-and-summarize 
using shorter, tiled k-mers, which validates this approach for small trimming values 
(three or less) (Fig S2.1a-b).  
Clustering of shape profiles across SELEX datasets 
Comparing the similarity of ΔR2p values between all SELEX datasets requires alignment 
and assessment of similarity between binding models generated by k-mer tables of 
different length. To align such cases we introduced an unbiased clustering scheme. 
Briefly, we applied a cubic spline interpolation to all shape profiles of a TF binding model 
to normalize them to 1000 points (function interp1d, from scikit-learn). Sometimes shape 
profiles can be mirrored and maximum ΔR2p values can be recovered in opposite positions 
across binding models (e.g. a TF binding model of length 10 with maximum ΔR2p value at 
position 3 contains its complementary model with maximum ΔR2p at position 7). To 
account for these cases we inverted the shape profile if the improvement in maximum 
performance was located at positions after the respective profile mean (position 500). 
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Using these shape profiles with common length, we clustered them using a partitioning 
around medoids (PAM) routine implemented by the pam function (package cluster in R) 
with a defined number of clusters between 2 and 10. For each cluster, we calculated a 
cluster-specific TF family and TF enrichment as the odds ratio between the number of 
datasets for a TF family or a TF associated to this cluster versus the number of datasets 
for that same TF family or TF in all others clusters (Fisher’s exact test, using function 
fisher_exact, from scipy). Significance p-values were corrected using the Benjamini 
Hochberg procedure. To select the reported number of clusters (five), we iteratively 
assessed the total number of TF and TFs families reported as enriched, stopping at the 
minimum clustering value that maximizes the number of raw p-values lower than 0.05 
(Fig S1.5a). 
Analysis of Forkhead-Ets members using shape profiles 
To compare shape profiles of double and matched single TF datasets that have a common Forkhead TF 
member, we studied the ΔR2p values for FOXO1 and FOXI1, as the corresponding CAP-SELEX 
datasets are enriched in cluster 1 and most of their TF-pair combinations have an 
equivalent topology. To align TF binding models generated from CAP-SELEX and HT-
SELEX, we used the consensus sequence motif of the Forkhead TF (listed in the reference 
k-mer) as an anchor point. Then, we maximized the number of matches between the 
Forkhead motif region and the reference consensus sequence across all composite motifs 
(FOXO1: RWMAAAC;FOXI1: RTMAAC). For ETS1, we used the GGAA pattern for alignment. 
HT-SELEX data for comparison was retrieved for FOXO1, FOXI1 and ETS1 using the 
available IDs in each case. Since these datasets capture short motifs, shape profiles can be 
generated using a single k-mer representing the consensus binding motif. Reference k-
mers were used as in the CIS-BP database [Weirauch et al. 2014]. For aligning and 
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comparing the profiles with the respective profiles for FOXO1, FOXI1 and ETS members we 
matched HT-SELEX k-mers to the respective composite k-mers reported for FOXO1 and 
ELK3 (ETS1 paralog), using the individual core motif for alignment, respectively. 
FOXO1:ETS1 crystal structure is visualized in PyMOL [DeLano et al. 2009] from PDB 
ID:4LG0, and enhanced with the PDIviz software [Ribeiro et al. 2016]. Conservation of 
positive charge in the ETS1 residue 409 is calculated from the Pfam ID PF00178 (Ets-
domain). 
TF-TF motif enrichments in co-occupied ChIP-seq peaks 
ChIP-seq peaks used to assess TF-TF motifs in vivo were retrieved from the ReMap2 
database [Cheneby et al 2018]. Matched TF pairs from CAP-SELEX data were associated to 
ChIP-seq data when peaks for both TFs were available. For obtaining common summit 
regions, we intersected the respective peak ranges centered around the peak summit with 
fixed length of 200 bp using bedtools (function intersect). These co-occupied regions 
are defined as the foreground set of peaks for each TF-TF pair. We discarded TF pair 
datasets that had less than 50 co-occupied peaks, recovering a total of 105 datasets. The 
background set, was defined as follows: For each foreground set, an equal number of 200 
bp-long sequences with similar %GC content distribution was obtained from mappable 
hg19 regions (wgEncodeCrgMapabilityAlign36mer, downloaded from 
http://hgdownload.cse.ucsc.edu/goldenpath/hg19/encodeDCC/wgEncodeMapability), using the BiasAway 
software package [Worsley-Hunt et al. 2014]. 
To map motifs in these sequences, we prepared Position Weight Matrices (PWMs) from 
the Position Frequency Matrix provided in the CAP-SELEX dataset [Jolma et al. 2015]. In 
both foreground and background sequences we scored the best PWM motif hit per 
sequence, as the sequence that generates the highest score. These scores are used to 
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define single feature models, labeled as PWM. Additionally, to define PWM+shape models 
[Mathelier et al 2015], we extracted the DNA-shape features obtained for genomic 
regions aligned to all positions where a motif hit was obtained, using bwtool. 
The ability of these features to separate foreground from background regions in each 
dataset was assessed as a classification task using Gradient boosting tree classifiers 
(XGBClassifier library [Chen et al 2016]). Predictive features were independently centered 
and scaled. In a 10-fold cross validation scheme, the overall classification performance 
for each model and dataset was summarized as the median Area Under The Receiver 
Operating Characteristic Curve (ROC-AUC). 
To assess the improvement of TF families in in vivo datasets when using 1mer+shape vs 
1mer models, we used their JASPAR family assignments, equivalently to the in vitro data 
analyses. For each TF family we specifically compared whether the ROC-AUC value 
differences between PWM+shape and PWM models (ΔROC-AUC) were significantly higher relative 
to all other datasets. Significance of the comparisons was assessed by a Wilcoxon rank sum test, and p-
values were corrected using the Benjamini Hochberg procedure. 
in vitro and in vivo positional improvement correlations 
Similar to the ΔR2p calculation in SELEX data, we generated ΔROC-AUC values per position for in vivo 
data, calculating changes in classification performance after addition and removal of 
shape features in each position i on in vivo models. 
(i) a = max(ΔROC-AUC(PWM,PWM +shapei), 0) 
(ii) b = max(-ΔROC-AUC(shapei, shapei -shapei), 0) 
(iii) ΔROC-AUC per position = min(a, b)  
In each matched TF-TF dataset with CAP-SELEX and ChIP-seq data, we aligned and compared ΔR2p values 
obtained from in vitro 1mer+shape models and ΔROC-AUC per position values obtained from in vivo 
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PWM+shape models using Spearman correlation. To estimate a False Discovery Rate (FDR) 
threshold for these correlation values, we scrambled correlation values in each model 
once and recalculated correlations. 
Enrichment of cooperative and non-cooperative k-mers in Forkhead-Ets ChIP-
seq data 
Selected sequences from our structural validation were mapped into co-occupied peaks to 
assess their enrichment versus single TF occupied peaks across TF pairs from the 
Forkhead and Ets families. Briefly, we mapped consensus sequences representing ω-none 
and ω motifs (GTAAACAGGAA and AACAACAGGAA, respectively), against Forkhead and 
Ets ChIP-seq in pairs, allowing up to one mismatch in each reported match. This 
threshold is chosen as it increases the recovery of sequences similar to each pattern, with 
a minimum overlap between hits in both categories. To compare the number of hits 
between co-occupied and single TF occupied peaks in each TF pair combination, we 
calculated the odds ratio of the number of sequences that do or do not containing either of 
these patterns in co-occupied versus single TF occupied regions: 
OR = [a / b] / [c / d] 
a is the number of co-occupied peaks with the motif; b is the number of co-occupied 
peaks without the motif; c is the number of single TF occupied peaks with the motif, and d 
is the number of single TF occupied peaks without the motif. We used a Fisher’s exact 
Test to assess the significance of these effect sizes across all assessed TF pairs, correcting 
p-values for multiple testing with the Benjamini Hochberg procedure. 
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TF pairs and ontology association analyses 
Similar to the previous section, we prepared co-occupied and single TF occupied ChIP-
seq regions for all TF pairs in the ReMap2 database, with full or partial match to CAP-
SELEX data. Full match indicates that both TFs in the ChIP-seq data are the same as in the 
CAP-SELEX data. Partial matches are two TFs that belong to the same TF family, and are 
annotated based on the idea that TF pair share composite motifs that are conserved 
within paralogs of the same family [Narasimhan et al 2015]. This knowledge can be used 
to extend the search to TFs of the same family for which no CAP-SELEX data is available. 
An example of this is provided with the TF pair FOXO1:ETV4: Both TFs are present in a 
CAP-SELEX dataset, and there are ReMap2 ChIP-seq peaks available for FOXO1, ETV1, 
ETV4 and ETV6. Thus, the TF-TF k-mers for FOXO1:ETV4 are used to scan co-occupied 
ChIP-seq regions of FOXO1:ETV4 (full match), FOXO1:ETV1 (partial match) and 
FOXO1:ETV6 (partial match). To assign co-occupied and single TF occupied ChIP-seq 
peaks to biological processes, we first used the software GREAT [CY McLean et al 2010] 
with default parameters to map peaks to genes: Peaks are selected if located upstream of a 
Transcription Start Site (TSS) up to 5000 bp, downstream of a TSS up to 1000 bp, or 
nearby genes up to 1000 Kbp away from a TSS and in absence of other nearby genes. We 
then assigned genes to ontologies if they are listed in any of the three following 
ontologies: Gene Ontology Consortium (GO), Human Phenotypes Ontologies (HPO), and 
DISEASES database. We only considered terms with at least 10 and no more than 1000 
genes, to focus our analysis on terms with an amount of associated genes that allows 
interpretation. 
Using this information, we sought to predict the membership of one or two TFs in a given 
ontology term, and use this as a proxy for their joint binding being associated to a 
biological function. This prediction is calculated using co-occupied TF peaks and 
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counting the number of peak-gene pairs that are part of the ontology term in question. 
Co-occupied peaks are further stratified as cooperative (using the cooperativity k-mers) 
and non-cooperative.. We assumed that a TF pair (A,B) is more likely involved in an 
ontology term (ont) based on the number of genes (𝑁𝑔𝑒𝑛𝑒) and peaks (𝑁𝑝𝑒𝑎𝑘) reported as 
part of that ontology term when using co-occupied (A∩B) peaks and their peak-gene 
pairs. For any ont and (A,B) combination, 𝑁𝑔𝑒𝑛𝑒is lower or equal than 𝑁𝑝𝑒𝑎𝑘, as multiple 
peaks can be mapped to the same gene (𝑁𝑔𝑒𝑛𝑒 ≤ 𝑁𝑝𝑒𝑎𝑘). 
The probability of a TF pair (A,B) to be associated with any ont 𝑃(𝑜𝑛𝑡 = 1 | 𝐴,𝐵),  is directly 
proportional to 𝑁𝑔𝑒𝑛𝑒  and 𝑁𝑝𝑒𝑎𝑘. 
𝑃(𝑜𝑛𝑡 = 1 | 𝐴,𝐵)  ∝  𝑁𝑔𝑒𝑛𝑒(𝑜𝑛𝑡 | 𝐴 ∩ 𝐵) 
 
𝑃(𝑜𝑛𝑡 = 1 | 𝐴,𝐵)  ∝  𝑁𝑝𝑒𝑎𝑘(𝑜𝑛𝑡 | 𝐴 ∩ 𝐵) 
To normalize 𝑁𝑝𝑒𝑎𝑘 and 𝑁𝑔𝑒𝑛𝑒 across all ontology terms and (A,B) combinations tested, we 
randomly sampled 200 times a number of unique regions equal to the observed number of 
𝐴 ∩ 𝐵 from the original union of regions belonging to A and B (𝐴 ∪ 𝐵), and recalculated 
decoy 𝑁𝑝𝑒𝑎𝑘 and 𝑁𝑔𝑒𝑛𝑒 values. From those we obtained mean (𝜇 ) and standard deviation 
(𝜎 ) estimates for the expected 𝑁𝑔𝑒𝑛𝑒 and 𝑁𝑝𝑒𝑎𝑘 associated to that ontology in case of a 
false association. This is used to convert 𝑁𝑝𝑒𝑎𝑘 and 𝑁𝑔𝑒𝑛𝑒 into z-scores 
𝑍𝑔𝑒𝑛𝑒 = (𝑁𝑔𝑒𝑛𝑒(𝑜𝑛𝑡|𝐴 ∩ 𝐵)  − 𝜇𝑔𝑒𝑛𝑒) / 𝜎𝑔𝑒𝑛𝑒 
 
𝑍𝑔𝑒𝑛𝑒 = (𝑁𝑝𝑒𝑎𝑘(𝑜𝑛𝑡|𝐴 ∩ 𝐵)  − 𝜇𝑝𝑒𝑎𝑘) / 𝜎𝑝𝑒𝑎𝑘 
 
Equivalently, when using TF-TF k-mers the association between ont and (A,B) is 
proportional to the number of peaks and genes obtained when using A∩B peaks, with a 
selection for the presence of TF-TF k-mers in those peaks. This is indicated as 𝑁𝑔𝑒𝑛𝑒,𝑘and 
𝑁𝑝𝑒𝑎𝑘,𝑘,where k refers to the specific k-mer used 
𝑃(𝑜𝑛𝑡 = 1 | 𝐴,𝐵,𝑘)  ∝  𝑁𝑔𝑒𝑛𝑒,𝑘(𝑜𝑛𝑡 | 𝐴 ∩ 𝐵,𝑘) 
 
𝑃(𝑜𝑛𝑡 = 1 | 𝐴,𝐵,𝑘)  ∝  𝑁𝑝𝑒𝑎𝑘,𝑘(𝑜𝑛𝑡 | 𝐴 ∩ 𝐵,𝑘) 
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Similar to the previous z-scores, we also normalize 𝑁𝑝𝑒𝑎𝑘,𝑘 and 𝑁𝑔𝑒𝑛𝑒,𝑘 into z-scores using 
200 random samplings 
𝑍𝑔𝑒𝑛𝑒,𝑘 = (𝑁𝑔𝑒𝑛𝑒,𝑘(𝑜𝑛𝑡|𝐴 ∩ 𝐵,𝑘)  − 𝜇𝑔𝑒𝑛𝑒,𝑘) / 𝜎𝑔𝑒𝑛𝑒,𝑘 
 
𝑍𝑝𝑒𝑎𝑘,𝑘 = (𝑁𝑝𝑒𝑎𝑘,𝑘(𝑜𝑛𝑡|𝐴 ∩ 𝐵,𝑘)  − 𝜇𝑝𝑒𝑎𝑘,𝑘) / 𝜎𝑝𝑒𝑎𝑘,𝑘 
 
K-mer mismatch thresholds for each 𝐴 ∩ 𝐵, ont  k combination were defined so that they 
maximize 𝑍𝑔𝑒𝑛𝑒,𝑘 and 𝑍𝑝𝑒𝑎𝑘,𝑘 values. To do this, we allowed up to three mismatches in each 
k-mer to be mapped into a co-occupied peak, and recalculated the observed 𝑍𝑔𝑒𝑛𝑒,𝑘 or 
𝑍𝑝𝑒𝑎𝑘,𝑘 values. When multiple k-mers for a pair (A, B) are available, we selected the one 
that gives the highest 𝑍𝑔𝑒𝑛𝑒,𝑘 and 𝑍𝑝𝑒𝑎𝑘,𝑘values. 
Integrating the resulting four z-scores together, we defined an Ontology Association 
Probability (OAP) as the probability of an ontology term associated to a TF-pair (A,B) 
𝑂𝐴𝑃 = 𝑃(𝑜𝑛𝑡 = 1 | 𝑍𝑝𝑒𝑎𝑘,𝑍𝑔𝑒𝑛𝑒 ,𝑍𝑔𝑒𝑛𝑒,𝑘,𝑍𝑝𝑒𝑎𝑘.𝑘)  
This probability is modeled based on the four Z-scores obtained above using a Logistic 
Regression 
𝑂𝐴𝑃 =  1 /(1 +  𝑒  −(𝛽0+𝛽1𝑍𝑝𝑒𝑎𝑘+𝛽2𝑍𝑔𝑒𝑛𝑒+𝛽3𝑍𝑔𝑒𝑛𝑒,𝑘+𝛽4𝑍𝑝𝑒𝑎𝑘.𝑘)) 
 
where 𝛽0 defines the intercept and 𝛽1 to 𝛽4 the Logistic Regression coefficients for each Z-
score. This model is limited by the availability of ChIP-seq data, and can be potentially 
extended as new information is included. If no ChIP-seq data is available, then TSS k-mer 
information can be considered, and Z-score calculations can be obtained using down 
sampling from all genes (Fig S2.7c). 
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Classification benchmark and selection of strong associations between 
ontologies and TF pairs. 
To benchmark this modeling scheme, we tested its ability to distinguish ontology terms 
deemed as positive if one or both TFs in (A, B) are listed as genes of the term: “TF1 or 
TF2” are TF-ontology relationships where one of the TFs is a gene member of that 
ontology term, whereas “TF2 and TF2” contain both TFs as members of that ontology 
term. Note these two examples: (i) the HPO term HP:0002488 (Acute leukemia) includes 
the TF ETV6, but not the TF FOXO1, thereby the TF pair FOXO1:ETV6 has a “TF1 or TF2” 
relationship to that particular ontology term (ii) The term HP:0002088 (Abnormal lung 
morphology) lists  both MITF1 and FLI1 as gene members, and thereby the pair MITF:FLI1 
has a “TF1 and TF2” relationship to that term. “background” terms are all ontology 
terms of which neither A nor B are members. 
We assessed the predictive performance of the Logistic Regression using a full model with 
all z-scores together (“peaks+kmers” = 𝑍𝑝𝑒𝑎𝑘 ,𝑍𝑔𝑒𝑛𝑒 ,𝑍𝑔𝑒𝑛𝑒,𝑘 ,𝑍𝑝𝑒𝑎𝑘.𝑘) and variants with only 
the peaks or k-mer z-scores (peaks = only 𝑍𝑝𝑒𝑎𝑘and 𝑍𝑔𝑒𝑛𝑒; k-mers = only 𝑍𝑝𝑒𝑎𝑘,𝑘 and 𝑍𝑔𝑒𝑛𝑒,𝑘). 
Performance metrics were defined by classification of “TF1 and TF2” terms versus 
“background” terms, or “TF1 or TF2” versus background terms, independently. Positive 
to negative ratios for between “TF1 and TF2” and “TF1 or TF2” versus background and 
total entries benchmarked in each ontology database are: HPO = 0.001 (N=99828) and 
0.05 (N=1715112); DISEASES = 0.001 (N=102420) and 0.04 (N=2808801), and GO = 0.004 
(N=166104) and 0.06 (N=906524). Using a 10-fold Cross Validation approach, we trained 
models on 9 portions of data and assessed the testing performance in the held-out 
portion, reporting the median ROC-AUC and Area Under the Precision Recall Curve (PR-
AUC) values using the trapezoidal rule. We compared significant improvement using an 
111 
 
independent t-test between the 10 testing performance metrics obtained in each model, 
correcting p-values using the Benjamini Hochberg procedure. 
To define strong and weak TF pairs and ontologies, we shuffled the ontology labels ten 
times to assess the OAP mean score that falsely labeled positive (decoy) terms when 
fitting a model with those. We observed that the majority of mean decoys OAP values are 
no bigger than 0.1, with slight variations across ontologies and models. Assuming that 
OAP values 0.1 units higher than this empirical mean threshold are unlikely false 
associations, we used this threshold to separate signal from noise: Any TF pair (A, B) and 
ontology association labeled as a “TF1 or TF2” or “TF1 and TF2” with a OAP value 0.1 
units greater than the mean of its decoys cases is considered a strong association. If 
multiple ontology terms for a TF pair satisfy this criteria, we visualize and discuss only 
the association with the highest OAP score (Fig S2.7b). For generating the Forkhead-Ets 
network, we additionally restrict all four Z-scores to be greater than zero. 
Overall survival calculations 
We compared overall survival metadata and RNA expression levels from Chronic 
Lymphocytic Leukemia patients (N=184) from a Blood Cancer cohort [Dietrich et al 2018]. 
Groups were separated using high and low expression levels for any TF pair of interest 
using the normalized counts median of given TFs. We compared between basic models 
where both TFs have low expression (low/low), versus models in which both genes have 
high levels (high/high), or models of the configuration high/low or low/high. Hazard ratios 
and confidence intervals are calculated using the survival package in R [TM Therneau et 
al 2018]. To correct for the immunoglobulin heavy chain variable gene (IGHV) and p53 
mutation statuses we assessed an additional model that indicates if the patient has either 
of those factors reported as positive, as a single category (N=88) (Fig S2.7d). Models with 
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patients with just one of the four combinations of these statuses are not reliable due to 
low sample numbers. 
Related to Chapter 3 
RNA-seq computational analysis 
We mapped RNA-seq reads in each sample to the M. musculus mm10 genome with 
TopHat2 [Kim et al 2013], defining the Gencode v10 transcriptome as a reference. We used 
mapped reads to call differentially expressed genes using DESeq2 [Love et al 2014]. We 
compared each treatment and time point against its matched control samples using all 
samples together to estimate dispersions, and calling for differentially expressed genes 
(DE-genes, with a false discovery rate (FDR) of 10%). 
We used unsupervised clustering to study the behavior of DE-peaks across conditions. 
Briefly, we selected genes with differential expression in at least one treatment and 
sorted them by significance and variance across conditions, selecting the top 5000 genes. 
We clustered the mean-corrected expression changes in each gene using partitioning 
around medoids (PAM) clustering, setting the number of clusters to ten. We compared the 
enrichment of gene ontology terms in each cluster versus other clusters using topGO 
[Alexa et al 2006], defining the whole genome as background. 
Chromatin accessibility data analysis 
We mapped ATAC-seq reads in each sample to the M. musculus genome build mm10 using 
bowtie [Langmead et al 2010] and with the following parameters. We used mapped reads 
to call peaks in each treatment and time point with MACS2 [Zhang et al 2008], 
considering pooled control samples as a background for all queries. The following 
parameters were defined to call peaks: “—nomodel –shift -75 –extsize 150”. Then, 
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we jointly analyzed resulting peaks and ATAC-seq reads to call differentially accessible 
peaks using the R package DiffBind [Ross-Innes et al 2010]. To correct counts per peak in 
all conditions we applied LOESS normalization. We conducted comparisons between 
experimental conditions and matched controls, obtaining a set of differentially accessible 
peaks at FDR=10% (DA-peaks), which are labeled as gained or closed based on their 
positive or negative log2 fold changes versus controls in each time point, respectively. 
We performed general genomic annotations for gained and closed DA-peaks in each 
treatment-time point pair using HOMER [Heinz et al 2010]. To assess the enrichment of 
neuron specific chromatin features, we applied a Hidden Markov Model generated from 
multiple chromatin marks and ChIP-seq data for mouse neurons, using ChromHMM 
[Ernst et al 2012]. This model considers 15 states in mm9. To interrogate our DA-peaks 
we converted ranges between mm10 and mm9 genome versions using liftOver [Hinrichs 
et al 2006]. We report the log2 fold enrichment between the number of nucleotides in one 
of the 15 states, versus the number of nucleotides overlapping with other states, using the 
function OverlapEnrichment. 
We used DA-peak enrichments for gene ontologies using binomial and hypergeometric 
tests as implemented in the GREAT server [CY McLean et al 2010], with default 
parameters to map peaks to genes. Peaks were selected if located upstream of a 
Transcription Start Site (TSS) up to 5000 bp, downstream of a TSS up to 1000 bp, or 
nearby genes up to 1000 Kbp away from a TSS and in the absence of other nearby genes. 
We used unchanged peaks as a background, to control for unspecific neuronal terms.  
Motif enrichment analysis 
We defined summit-centered 200-bp regions from all DA-peaks as foreground regions, 
and retrieved background regions for each one using GENRE [Mariani et al. 2017], and a 
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custom mm10 background. Briefly, a representative background sequence is retrieved 
from a mouse-specific database of reference regions, with equivalent GC-content and 
CpG frequency, promoter overlap (extent of the sequence located within 2 kb upstream of 
a TSS), and repeat overlap. Further details are provided in [Mariani et al 2017]. 
We used foreground and background sequences to map motifs using (i) 8-mers listed in a 
set of 108 transcription factor specificity groups generated from Protein Binding 
Microarray (PBM) data, and (ii) a library of Position Weight Matrices (PWMs) models 
(CIS-BP database [Weirauch et al 2011; Lambert et al 2018]). For 8-mers, we defined the 
best 8-mer score per sequence as the best E-score greater than 0.35, or -1 otherwise. For 
PWM motif hits we used the best motif score in each sequence as reported by FIMO [CE 
Grant et al  2011]. We used these scores to assess sensitivity and specificity using a 
Receiver Operating Characteristic (ROC) analysis, with foreground and background 
sequences in each treatment and time point as positive and negative groups, respectively. 
We used the Area Under the Curve (ROC-AUC), to define significantly enriched TF 
specificity modules and motifs. We used a Wilcoxon one-sided test, adjusted with a 
Benjamini Hochberg procedure, to assess enriched modules (FDR = 10% and ROC-AUC 
greater than 0.55). 
TF modules co-enrichment analyses 
We prioritized enriched TF-specificity modules (ROC AUC > 0.55) to assess their co-
enrichment in DA-peaks for specific combinations. Briefly, we compared the abundance 
of peaks with 8-mers for two of more modules. The enrichment of a specific combination 
of TFs together is DA-peaks is calculated using fold enrichment. The calculation of the 
exact probability for that fold enrichmentis calculated using the R package 
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SuperExactTest [Wang et al 2015], and P values are corrected using a Benjamini 
Hochberg procedure. 
In addition to this, we compared DA-peaks log2 fold changes distributions between peaks 
with two TF modules versus only one of both modules, using a Wilcoxon two-sided test. 
Genomic data co-variation and loop data analysis 
Peak pair correlations between called peaks from the processed ATAC-data were 
generated using all peak-pairs that had a maximum distance of 50 Kbp. Peaks were 
further analyzed with Hi-C to assess changes in correlation distributions, filtering for 
peaks with one Hi-C loop reported in cortical neurons, embryonic stem cells and neuron 
progenitor cells. We defined true loops as peak-peak pairs where both peaks are less than 
10 Kbp away from the coordinates of a Hi-C genomic peak. 
We studied the effects of DA-peaks on DE-genes assessing the enrichment of up-
regulated DE-genes proximal to gained DA-peaks. Briefly, we compared the amount of up 
DE-genes associated to a non-promoter gained DA-peak (peak-TSS distance greater 
than 2000 bp), and their log2 fold changes in each time point. When two DA-peaks are 
linked to one DE-gene, the one with the lowest p-adjusted value is selected. Then, we 
compared up-gained events (up-regulated DE-gene; gained DA-peak) with up-closed, 
down-gained and down-closed pairs using a 2 x 2 contingency table and Fisher’s exact 
test for assessment of enrichment. 
CTCF specific analyses at differentially accessible peaks 
To assess the enrichment of DA-peaks for CTCF promoter-exon loops we used a 
previously released dataset of promoter-exon contacts [Ruiz-Velasco et al 2017] to 
compare the odds ratio between DA-peaks in these loops versus unchanged peaks. We 
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used Fisher’s exact test to assess the overrepresentation of DA-peaks in those regions, 
versus unchanged peaks in those regions. We corrected p-values using the Benjamini 
Hochberg procedure [Benjamini et al 1995]. 
We assessed the enrichment of a convergent or divergent CTCF topology for motif hits in 
DA-peaks connected to promoter-exon loops. Briefly, gained and closed DA-peaks were 
that contain at least one CTCF motif hit (CIS-BP ID M06483_1.94d) [Weirauch et al 2011] 
were assessed for enrichment of promoter-exon loop pairs previously reported in [Ruiz-
Velasco et al 2017].  We quantified Odds Ratios (OR) using the formula 
OR = [a / b] / [c / d] 
Where a is the number of DA-peaks with a CTCF motif and part of promoter-exon; b is the 
number DA-peaks without a CTCF motif and in a promoter-exon look; c is the number of 
non-DA peaks with a CTCF motif and in a promoter-exon loop, and d is the number of 
non-DA peaks without a CTCF motif and in a promoter-exon loop. We used a Fisher’s 
exact Test to assess the significance of these effect sizes across treatments (BDNF and 
KCl) and directions (gained and closed peaks), correcting p-values for multiple testing 
with the Benjamini Hochberg procedure. 
 
Differentially used exons analyses 
To call differentially used exons we used mapped RNA-seq reads to obtain count tables 
for all listed exons in Gencode (v10). We used genes with non-zero counts in at least one 
treatment and time point to perform comparisons between BDNF and KCl matched time 
points, using DEXSeq [Anders et al 2012] to call differentially used exons (FDR=10%). To 
filter for cases related to CTCF promoter-exon loops, we selected genes containing 
differentially used exons and CTCF promoter-exon loops from [Ruiz-Velasco et al 2017]. 
  
Related to Chapter 4 
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Appendix B 
 
Experimental Materials and Methods 
 
Related to Chapter 2 
Protein cloning, expression and Purification 
 
The ETS1 (331-440) and FOXO1 (143-270) sequences were purchased using Geneart 
(ThermoFisher). These were amplified and cloned using restriction free cloning into a 
pETM-22 vector, which comprises a cleavable N-terminal His6- and Trx-tag. The single 
mutations were inserted in the pETM-22-ETS1 (331-440) vector using site directed 
mutagenesis. 
Both proteins were expressed and purified from E. coli BL21 (DE3), grown in LB medium. 
The cultures were induced with 0.2 mM IPTG at an OD600 of 0.8 and grown overnight at 
18°C. 
After resuspension of the cells in a buffer containing 50 mM Tris (pH 7.5), 300 mM NaCl, 
0.5 mg/ml lysozyme, EDTA free protease inhibitor (Roche) and benzonase, the cells were 
lysed using a french press. The cleared lysate was applied to a first Ni-NTA column and 
after washing eluted with an imidazole gradient from 0 to 300 mM. The eluted protein 
fractions were then cleaved with 3C-protease overnight at 4°C to remove the His6-tag and 
simultaneously dialyzed against 0 mM imidazole, 50 mM Bis-Tris (pH 6.5) and 150 mM 
NaCl. After a second Ni-NTA purification FOXO1 was applied to a S75 gel-filtration 
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column (GE) equilibrated at 50 mM Bis-Tris and 150 mM NaCl. ETS1 purification involved 
an additional purification step using a Heparin column to remove DNA. The protein was 
eluted using a salt gradient from 50 mM to 2 mM NaCl. For NMR titration and backbone 
assignment experiments of FOXO1 the same purification steps were performed but 
Minimal medium M9 has been used to isotopically enrich the protein. For 15N- and 15N, 
13C-labeled protein expression, 15NH4Cl or 15NH4Cl and 13C-Glucose were used as sole 
nitrogen and carbon sources, respectively. The final NMR and ITC buffer was 50 mM Bis-
Tris, 150 mM NaCl, pH 6.5. 
Isothermal Titration Calorimetry 
Titrations were carried out using either a MicroCal PEAQ-ITC or a MicroCal iTC200 
calorimeter at 25ºC. All protein and DNA samples were dialyzed overnight at 4ºC against 
the same buffer containing 50 mM Bis-Tris, pH 6.5 and 150 mM NaCl. For each titration 
20 injections of 2 µl of titrant were made at 120 s intervals, while stirring at 750 rpm. Data 
were reduced with heat spikes from control and baseline corrected. The raw data 
integration, normalization and titration curve fitting was done using the MicroCal PEAQ-
ITC analysis software provided by Malvern. 
NMR 
All NMR measurements were performed at 298 K on an Avance III Bruker NMR 
spectrometer with a magnetic field strength, corresponding to a proton Larmor frequency 
of 600 MHz, equipped with a cryogenic triple resonance gradient probe head. Backbone 
resonance assignment of FOXO1 was achieved to a completion of 85 % (excluding 
prolines) using 1H,15N-HSQC, HNCA, CBCA(CO)NH and HNCACB triple resonance 
experiments [Sattler et al 1999] analyzed with CARA (http://cara.nmr.ch ). 
For all NMR titration experiments a series of 1H,15N-HSQC spectra were recorded of 15N-
labeled FOXO1 in absence or presence of equimolar unlabeled ETS1. Different DNAs 
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(labeled as ω-none, ω and ω-high) were titrated always with the same series of molar 
equivalents (0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 1.0, 1.2) to protein concentration (100 µM). 
As the DNA stock solution was highly concentrated (10 mM), the dilution effect was 
negligible but still taken into account. All spectra were processed using NMRPipe 
[Delaglio et al 1995] and data analysis was performed using the program Sparky [Lee et al 
2015] for chemical shift perturbation analysis and CCPN for determining dissociation 
constants by fitting the fast exchange chemical shift perturbations vs. DNA concentration 
using 𝐴(𝐵 + 𝑥 − �(((𝐵 + 𝑥)2 − 4𝑥))  as a fitting function [Vranken et al 2005]. 
 
Related to Chapter 3 
Primary cortical neuron culture 
Prenatal embryos of CD-1 mouse at embryonic day 15 (E15) were used for the isolation of 
cortical neurons. Embryonic cortex was isolated and dissociated by chopping with scalpel 
followed by digestion in Accutase (ThermoFisher, A1110501) for 12 mins at 37°C. During 
digestion we treated the tissue with 250 unit/µL of Benzonase (Millipore, 71206-3) to 
prevent neuronal clumping due to genomic DNA released from dead cells. Following 
digestion, neurons were triturated gently and passed through the 40µm cell strainer (BD 
Falcon, 352340) before plating them onto 6 well plate at a density of 1x106 cells per well. 
Tissue culture plates were coated with 0.1 mg/mL of Poly-D-Lysine (Sigma, P0899) and 
2.5 μg/mL of laminin (Sigma, 11243217001). Primary neuronal cultures were maintained 
in Neurobasal medium (ThermoFisher, 21103) containing 1% penicillin/streptomycin 
(ThermoFisher, 15140122), 1% GlutaMAX (ThermoFisher, 35050), and 2% B27 
supplement (ThermoFisher, 12587) at 37°C with 5% carbon dioxide in the incubator. 
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Post-seeding after 1 day in vitro (DIV1), half of the media was replaced with fresh pre-
warmed Neurobasal media with all the supplements.  
Stimulation with BDNF, KCl and forskolin. 
Prior to every stimulation on DIV7, neurons were made quiescent for 2 hours with 100 μM 
DL-2-amino-5-phosphonopentanoic acid (DL-AP5; Fisher) and 1 μM tetrodotoxin (TTX; 
Tocris). KCl (55mM) depolarization was performed by adding warmed KCl depolarization 
buffer (170 mM KCl, 2 mM CaCl2, 1 mM MgCl2and 10 mM 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid (HEPES)) to a final concentration of 31% directly into the 
neuronal culture medium and incubated for 1, 6, and 10 hour For the BDNF and forskolin 
stimulations, neurons were incubated with BDNF (10 ng/ml) and forskolin (10 μM) on 
DIV7 for 1, 6, and 10 hour. 
RNA-seq sample preparation and analysis 
Mouse cortical neurons were collected at 1, 6, and 10 hours after each stimulation for RNA 
isolation. The RNAeasy kit (Qiagen) was used to extract RNA and genomic DNA was 
digested using the Turbo DNAse kit (Ambion). To assess the quality of RNA all samples 
were analyzed using Bioanalyser (Agilent Genomics). Only samples with a RIN (RNA 
integrity number) score above 9 were used for library preparation. To prepare libraries we 
used the oligo-dT capture kit (NEB) in combination with the NEBNext Ultra II kit. We 
pooled 24 samples with each sample carrying a distinct barcode and sequenced on 
NextSeq 500 at EMBL, Heidelberg Gene Core facility.  
Differentially used exons analyses 
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Exon differential exon usage quantification with qPCR 
For experimental validation, exons were selected based on the presence of a differential 
DUE and a promoter-exon CTCF loop. Primary cortical neuron cultures on DIV 7 were 
stimulated and RNA was isolated for expression analysis of the DUEs. Primers for exons of 
three gene examples were selected, in addition to neighboring exons for internal control. 
The exon 29 with additional 3’UTR sequence is a DUE for Trio. Two primers were designed 
to differentiate exon 29 (DUE) from constitutive exon 28. A forward primer lies within the 
coding region of exon 29 with a reverse primer in the immediately downstream 3’UTR 
region. Both forward and reverse primer lies in the coding region of exon 28. For Stxbp5 
again primers were designed to allow selective amplification of DUE which is exon 1 
against a constitutive exon 5. Similarly for Cpe-201 two set of primers were designed, one 
for exon 6 which is a DUE and another for constitutive exon 9. The primer sequences used 
to perform qPCR analysis for DUE are following. Trio: Exon 29+3’UTR Forward (5’ 
CTCAGAGCAACGGGGTAAGAG 3’) and Reverse (5’ GTGCTGGAGAGCTGGAGTTAG 3’); Exon 
28 Forward (5’ TGAGTTGCCTCTGCTTGGAG 3’) Reverse (5’ GGACGCTTGGACTGGATGAA 
3’). Stxbp5: Exon 1 Forward (5’ CAACATCAGGAAGGTGCTGG 3’) Reverse (5’ 
GAAGTGTTCGGACTGGAGCG 3’); Exon 5 Forward (5’ TGCCATCTGCCTTTCCAGAG 3’) 
Reverse (5’ TGACATAGCCTGAGAGTGTGA 3’). Cpe-201: Exon 6 Forward (5’ 
TGCTTCGAGATCACTGTGGAG 3’) Reverse (5’ CTGCTCCAGGTAGCTGATGA 3’); Exon 9 
Forward (5’ TGTCTGGATCTACTTCATTCTTACA 3’) Reverse (5’ 
CGCAGTACAGGGTTCACAGA 3’). Following stimulation with BDNF and KCl, the fold 
change of each exon was quantified using qPCR and comparison against Rpl13 as a 
reference gene at 1 and 6 hours. Fold change values were used to calculate the exon ratio 
between each tested exon and their internal exon as a reference. 
Related to Chapter 4 
 
Contents embargoed until Sep 15 2021 
 
  
126 
 
Appendix C 
 
Supplementary Material
 
Related to Chapter 2 
 
Figure S2.1. Selection of tiled k-mers cutoff using HT-SELEX data. 
(a) Depiction of tiled k-mer approach applied to HT-SELEX data analyzed by Yang et al [Yang et al 2017]. 
Briefly, reference k-mers defined in this work are tiled increasingly, and the correlation between ΔR2 estimates 
from 1mer+shape versus 1mer models is calculated. (b) Spearman correlation between tiled k-mers and 
reference k-mers. Red line indicates rho = 0.5, and threshold for selection of tiled k-mers in CAP-SELEX data. 
(c) Fraction of maximum variance per R2 dataset using different model configurations. 1mer+shape model have 
higher performances than 1mer+2mer and lower than 1mer+2mer+3mer, which require more features (d) 
Comparison between 1mer+2mer+3mer and 1mer models. Forkhead+Ets datasets show similar improvements 
and trends as in Fig 1b. (e) ΔR2 values observed for Forkhead+Ets datasets after removing k-mers containing 
bi-specificity related pentamers (GACGC) from Forkhead datasets (Appendix A). Asterisks as defined in Fig 1c. 
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Figure S2.2. FOXO1:ETS1 binding against cooperative and non-cooperative DNA sequences measured with 
ITC. 
ITC calorimetric titration data. Upper plots represent raw data, and lower plots indicate integrated heat of 
binding reaction. Line in scatter plots represent best fit to the data. Values in lower-right box indicate 
thermodynamic parameter estimates and their standard deviation (N=2 in each case). Lower panels indicate 
ΔG parameters (red) for FOXO1 and FOXO1:ETS1 when tested against DNA sequences predicted to have high 
binding affinity (ω-none) and lower affinity and cooperativity upon addition of ETS1 (ω)  
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Figure S2.3. FOXO1:ETS1 binding against cooperative and non-cooperative DNA sequences measured with 
NMR. 
 (a) Full 1H–15N HSQC spectra for FOXO1:ETS1 protein interacting with ω-high. Colors indicate DNA to protein 
concentration ratios. Highlighted peak residue indicate titration peak for FOXO1 residue K192H-H (b) Titrated 
peak G230N-H from FOXO1 and behavior for three DNA sequences for FOXO1 and FOXO1+ETS1. Titration color 
scale as in Fig 2.2e 
 
129 
 
 
 
 
 
Figure S2.4. Protein Binding Microarray and SELEX comparison for k-mers containing cooperative and 
non-cooperative Forkhead-Ets sequences. 
 (a) Protein Binding Microarray E-scores distributions for Forkhead family members. Each boxplot shows a 
group of 8-mers containing the 7-mer in Forkhead region (ω-none = GTAAACA; ω = AACAACA; ω-high = 
ACGCACC). Red line indicates 0.35, threshold that defines high affinity sites (b) (left) Relative affinity values 
for 10-mers containing patterns related to ω-none and ω. X-axis indicates increasing HT-SELEX selection 
rounds. The distribution of relative affinities for k-mers containing the high affinity FOXO1 site is inverted at 
round 3 and 4 with respect to initial rounds. (right) Relative affinities for 10-mers obtained from CAP-SELEX 
data from FOXO1 and TF partners. X-axis indicates experiment ID, including TF1, TF2, selection round and 
barcode ID. 6 out of 9 comparisons show no differences in relative affinities distributions. Statistical 
comparisons were done using independent t-test, with Benjamini Hochberg correction procedure. 
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Figure S2.5. Benchmark of improvements per position consistency in HT-SELEX data. 
Related to Figure 3 (a) tiled k-mers defined as shorter versions of the core motifs in HT-SELEX data analyses 
are used to study agreements observed in positional improvements by addition and removal of DNA-shape 
features. The estimated positional effect of all k-mers is compared with the effect observed with the model 
that uses the longest k-mer, using correlations (b) Distribution of correlations for all observed datasets 
(median Spearman correlation=0.31). (c) (upper) POU2F2 motif generated from top 100 k-mers by relative 
affinity (reference k-mer = NNNNWAATNNNN) (middle) Comparison between improvements per position 
generated using reference k-mer (blue line) and tiled k-mers (orange line) (Spearman correlation = 0.85) 
(bottom) Heatmap depicting ΔR2p values obtained for each tiled k-mer. Stronger biases are consistently 
obtained between positions one and five (d) Comparison of L2-coefficients for Minor Groove Width Features 
in CEBPB binding model obtained from HT-SELEX data, tiling 3 positions from reference k-mer. (top) CEBPB 
motif generated as in S4c. (middle) L2-coefficients for tiled k-mer aligned to that region of the reference k-
mer. (bottom) Number of times coefficients are in agreement for the same sign in each position. 
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Figure S2.6. Positional improvements in CAP-SELEX data and Forkhead+Ets interactions 
(a) Analysis of TF families enriched during PAM clustering of shape profiles for increasing number of clusters. 
Plateau is reached at five (three TFs families and two TFs. (b) Related to Fig 3b. (upper) Distribution of CAP-
SELEX datasets by TF family (lower) enrichment values (* = p-value < 0.05. Black box = Adjusted P < 0.1) (c) 
Absolute changes in R2 for CAP-SELEX models containing FOXO1, using individual DNA-shape properties. (d) 
Related to Fig 2.3c. (right) Comparison between relative R2 FOXI1 in CAP-SELEX (blue) and values obtained 
from HT-SELEX data (orange line) (e) Related to Fig 2.3d. Reference k-mers of FOXI1 datasets aligned, and 
comparison of positional improvements after alignment (f) Related to Fig 2.3f. Dissociation constant 
measurements for FOXO1 to ω-medium alone (N=2) upon addition of ETS1 (N=2) or mutant Y410A (N=1). 
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Figure S2.7. TF-TF associations to phenotypes using Ontology Association Probability. 
Related to Figure 5 (a) “TF1 or TF2” benchmark results, when using OAPs to recover those associations with 
respect to background terms. Labels and p-values equivalent to Figure 5c. (b) Five strongest associations by 
ontology database using the category “TF1 and TF2” to assign TF pairs to ontologies. Red line indicates mean 
OAP for decoy terms (c) Related to Figure 6 (top) Ontologies related to differentiation and disease show a 
strong association to specific TF-TF pairs where at least one TF is known be related to that particular process. 
(bottom) Motifs related to each column are highlighted and grouped by their TF-TF names. When more than 
one topology exists, the motif with the highest score is highlighted in a black rectangle. (d) Kaplan-Meier plot 
of overall survival in CLL patients subsetted by IGHV and p53 mutation statuses (N=88). Data, P values and 
expression groups for FOXO1 and ETV6 are defined equivalently to Fig 6b. 
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Related to Chapter 3 
 
 
Figure S3.1 RNA-seq computational data processing 
(a) (top) Mean of two replicates for mapped reads per chromosome in each time point and treatment 
combination (bottom) Total number of reads mapped in each biological replicate, in each condition and time 
point (b) Principal component analysis visualization for treatment and time points according to DESeq2 
normalized counts. (c) Pearson correlation between mapped reads across treatments. (d) Correlation between 
log2 fold changes obtained in our analysis with matches DE-genes reported mouse neurons stimulated with KCl 
[Ataman et al 2016] 
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Figure S3.2 ATAC-seq computational data processing 
 (a) (top) Mean of two replicates for mapped reads per chromosome in each time point and treatment combination 
(bottom) Total number of reads mapped in each biological replicate, in each condition and time point (b) Principal 
component analysis visualization for treatment and time points using normalized counts generated with DiffBind 
(c) Differentially accessible peaks (DA-peaks) obtained when comparing 1h ATAC-seq samples versus controls for 
KCl (left), BDNF (middle) and Forskolin (right). Red points indicate a peak with accessibility levels higher (log fold 
change > 0) or lower (log fold change < 0) than matched controls (FDR=10%). 
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Figure S3.3 Genomic features of ATAC-seq peaks 
Related to Figure 3.2c (a) Percentage distribution of DA-peaks for BDNF and KCl 1h in peak annotations 
(HOMER) (b) Chromatin states enrichments in DA-peaks for neuronal marks, based on ChromHMM 15-states 
model. Labels and descriptions as in Figure 3.2.  (c) Correlation distributions for normalized counts of 
proximal peak pairs (CN=cortical neurons; NPC=neural progenitor cells; ES=Embryonic stem cells) (Appendix 
A). (d) Example of correlation between ATAC-seq peak in Arc gene and a DRE upstream of it  
 
 
 
136 
 
 
 
 
Figure S3.4 Features of 8-mers for known TFs in ATAC-seq DA-peaks 
(a) For DA-gained peaks, 8-mers modules are visualized by its overall enrichment (Area Under the Receiver 
Operating Characteristic Curve, AUROC) versus the median relative distance to the peak summit for all 
observations. bZIP has the highest enrichment and additionally the lowest median distance to summit for 
BDNF 1 and 6h. (b) Percentage of DA-peaks explained by enriched TF motifs (ROC AUC > 0.55). 
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Figure S3.5. k-mers co-enrichments in BDNF vs KCl data 
 (a) Co-enrichments for selected TF specificity models in BDNF and KCl for gained DA-peaks (b) Similar to (a) 
for closed DA-closed peaks. KCl terms are sorted similar to BDNF for visual comparison. Fold Enrichments for 
five first terms are highlighted in parenthesis (P indicates p-values calculated hypergeometric [Wang et al 
2015] (Appendix A). (c) Relationship between accessibility changes in ATAC-seq and presence of HIC1, EGR, 
and bZIP motifs in BDNF at 1h. Asterisks indicate P < 0.1 using one sided Wilcoxon’s test, after Benjamini 
Hochberg procedure. 
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Figure S3.6. Enrichment of ATAC-seq peaks with CTCF motifs in introns and exons  
(a) Enrichment scores for CTCF motifs in gained, closed and unchanged ATAC-seq associated to introns, and 
(b) exons. * indicates Fisher’s one sided exact test, with P values adjusted by Benjamini Hochberg procedure 
*, **, *** = P < 0.05, 0.01 and 0.001, respectively (Fisher’s exact test). 
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